gold has been researched along with Prostatic Neoplasms in 355 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (1.13) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 60 (16.90) | 29.6817 |
| 2010's | 203 (57.18) | 24.3611 |
| 2020's | 88 (24.79) | 2.80 |
| Authors | Studies |
|---|---|
| Bennie, LA; Coulter, JA; Emmerson, C; Feng, J; Hyland, WB; Matchett, KB; McCarthy, HO | 1 |
| Abi Tayeh, G; Albisinni, S; Aoun, F; Chebel, R; Khalil, N; Lilly, E; Mjaess, G; Peltier, A; Roumeguère, T; Sarkis, J | 1 |
| Chen, X; Deng, L; Ding, J; Liu, D; Xiang, Y; Yang, Q; Zhang, Y; Zhong, J | 1 |
| Katti, K; Katti, KV; Khoobchandani, M; Pasanphan, W; Piroonpan, T; Tangthong, T; Thipe, VC | 1 |
| Kalkan, NÖ; Suludere, Z; Tamer, U; Turan, E; Zengin, A | 1 |
| Güleryüz, B; Gülsoy, M; Ünal, U | 1 |
| Han, S; Lu, N; Lu, Z; Xiao, Y; Yan, R; Zhang, M; Zhao, Z | 1 |
| Alnajjar, S; Becker, A; Frank, M; Murua Escobar, H; Ngezahayo, A; Nolte, I; Schille, JT; Trakooljul, N | 1 |
| Ghasemi, M; Kempson, I; Sebastian, S; Turnbull, T | 1 |
| Ge, C; He, X; He, Z; Hou, L; Li, S; Wang, L; Wang, X; Xu, Y | 1 |
| Gao, D; Gao, S; Wang, R; Wang, S; Wang, X; Yang, Y; Zhou, G | 1 |
| Jeon, MJ; Kim, WH; Lee, JU; Park, KH; Sim, SJ | 1 |
| Basilion, JP; Burda, C; Luo, D; Ramamurthy, G; Springer, S; Walker, E; Wang, X | 1 |
| Ding, Y; Hong, X; Lu, Y; Wang, G; Wang, J; Wang, K; Wen, X; Xing, X; Zhao, H | 1 |
| Behyar, MB; Farshchi, F; Hasanzadeh, M | 1 |
| Belchior, A; Campello, MPC; Marques, A; Marques, F; Matos, APA; Paulo, A; Pinheiro, T; Santos, L; Santos, P; Silva, F | 1 |
| Batra, SK; Jain, M; Kshirsagar, P; Kumar, S; Mallya, K; Muniyan, S; Rachagani, S; Seshacharyulu, P; Shah, A; Smith, LM; Thompson, C | 1 |
| Feng, X; Gao, X; Hu, B; Niu, T; Tang, B; Xia, Q; Xu, K; Yang, J; Zhao, Z | 1 |
| Basso, CR; Castro, GR; Crulhas, BP; Pedrosa, VA | 1 |
| Akçay, Y; Ertuğrul Uygun, HD; Fedacı, C; Uygun, ZO | 1 |
| Che, S; Guan, L; He, L; Li, X; Lin, Q; Qu, W; Wang, Z; Xing, H; Yang, Z; Zvyagin, AV | 1 |
| Bogdanowicz, Z; Bombalska, A; Kasprzycka, W; Mierczyk, Z; Nasiłowska, B | 1 |
| Anttinen, M; Blanco Sequeiros, R; Boström, PJ; Mäkelä, P; Wright, C | 1 |
| Huang, J; Li, D; Yang, L; Zhao, S | 1 |
| Cai, S; Deng, Y; Li, Y; Lin, J; Xie, W; Yang, H; Ye, J; Zeng, J; Zhang, Y; Zhong, W; Zhuo, Y; Zou, F; Zou, Z | 1 |
| Alexander, A; Barta, I; Beckham, W; Bromma, K; Chithrani, DB; Dos Santos, N; Krishnan, S | 1 |
| Chen, Z; Jiang, W; Lu, J; Ma, Y; Ren, X | 1 |
| Baker, A; Khalid, M; Khan, MS; Uddin, I | 1 |
| Han, M; Liu, J; Song, Y; Wang, C; Wang, Y; Yan, F | 1 |
| Dhanapala, L; Jones, AL; Joseph, S; Kremer, RB; Lee, N; Moghaddam, S; Rusling, JF | 1 |
| Han, XX; Liu, Y; Ozaki, Y; Wang, J; Xu, B; Zhao, B; Zhao, J | 1 |
| Aljabali, AAA; Arshad, F; Birkett, M; Haggag, Y; Hassan, IU; Khan, R; Mishra, V; Mishra, Y; Naikoo, GA; Pedram, MZ; Pourfarzad, H; Serrano-Aroca, Á; Tambuwala, MM; Zedegan, MS | 1 |
| Li, J; Li, L; Li, X; Li, Y; Liu, L; Lu, H; Wang, J; Zhang, X; Zhu, Y | 1 |
| Bingham, K; Bragg, L; Curry, D; Jiang, R; Liu, J; Majtenyi, N; Nguyen, Q; Servos, M; Shaaer, A; Wang, F; Youden, B; Zhang, X | 1 |
| Adiraju, A; Al-Hamry, A; Alnaimi, A; Kanoun, O; Makableh, Y | 1 |
| Chen, Y; Du, TQ; Liu, R; Liu, Z; Luo, H; Sun, S; Tan, M; Tian, J; Wang, Q; Wang, X; Wu, X; Yang, K; Zhang, Q | 1 |
| Cheng, W; Khan, A; Kong, D; Li, J; Sun, Y; Yi, Y; Zhang, J; Zhang, Z; Zhao, G | 1 |
| Campello, MPC; D'Onofrio, A; Figueiredo, S; Gabano, E; Gano, L; Gonçalves, K; Marques, F; Mendes, C; Paulo, A; Pinheiro, T; Ravera, M; Silva, F | 1 |
| Baker, AN; Georgiou, PG; Gibson, MI; Neves, MMPS; Richards, SJ; Walker, M | 1 |
| Goldner, G; Moll, M; Stanisav, V; Weiß, M; Zaharie, A | 1 |
| El Hage, R; Fracasso, G; Ghanem, E; Minassian, G; Mitri, N; Rahme, K; Sarkis, M | 1 |
| Ghanem, E; Hage, RE; Minassian, G; Rahme, K | 1 |
| Aires, F; Correa-Duarte, MA; Faria, I; Fernandes, R; Guerreiro, SG; Monteiro, A; Pinto, G; Sales, MG; Soares, S | 1 |
| Correa-Duarte, MA; Fernandes, R; Guerreiro, SG; Oliveira, AC; Pereira, C; Sales, MG; Soares, S; Sousa, AP | 1 |
| Angnes, L; Felici, E; Fernández-Baldo, MA; Messina, GA; Ortega, FG; Pereira, SV; Regiart, MD | 1 |
| Cheng, Z; Han, X; He, C; Liu, R; Liu, Y; Ma, H; Song, L; Xu, B; Zhao, B; Zhao, J | 1 |
| Basilion, JP; Burda, C; Hostnik, ET; Joseph, M; Luo, D; Naidu, NG; Ponomarev, V; Ponsky, L; Ramamurthy, G; Rosol, TJ; Shakya, R; Shirke, A; Tweedle, MF; Walker, E; Wang, X; Zhang, L | 1 |
| Loblaw, DA; McGuffin, M; Smith, M; Wong, J | 1 |
| Mahdavi, A; Mofid, B; Taghizadeh-Hesary, F | 1 |
| Bellucci, L; Beltram, F; Luin, S; Matteoli, G; Nifosì, R; Signore, G | 1 |
| Chen, L; Fu, X; Li, J; Lin, H; Liu, Y; Tian, C; Wen, J; Zhuang, X | 1 |
| Huang, Y; Li, C; Li, G; Wang, Z; Xiang, Y; Xue, L; Yang, Y; Zheng, J | 1 |
| Bloebaum, P; Jurisson, SS; Katti, KK; Katti, KV; Khoobchandani, M; Panjtan Amiri, K; Raphael Karikachery, A; Thipe, VC | 1 |
| Anastos, H; Canfield, SE; Carrick, MR; Doppalapudi, SK; George, AK; Halas, NJ; Knauer, CJ; Lewis, SC; Rastinehad, AR; Schwartz, JA; Sfakianos, JP; Taouli, B; Tewari, AK; Wajswol, E; West, JL; Winoker, JS | 1 |
| Alghamdi, SS; Feltis, BN; Geso, M; Nakayama, M; Piva, TJ; Pouniotis, D; Shahhoseini, E | 1 |
| Hu, Z; Jia, Y; Li, L; Na, N; Ouyang, J; Sun, F; Sun, X; Xu, S | 1 |
| Abbasi, J | 1 |
| Ghavami, R; Shayesteh, OH | 1 |
| Taneja, SS | 1 |
| Changizi, O; Keyvan Rad, J; Khoei, S; Mahdavi, SR; Mahdavian, A; Shirvalilou, S | 1 |
| Abal, B; Engeseth, GM; Hysing, LB; Pilskog, S; Ytre-Hauge, KS; Øvrelid, KS | 1 |
| Gu, C; Ju, Y; Li, C; Li, X; Liu, Y; Wang, L; Xu, Y; Zhang, J | 1 |
| Farshchi, F; Hasanzadeh, M; Mokhtarzadeh, A | 1 |
| Ebrahimi, M; Khoei, S; Mahdavi, SR; Mahdavian, A; Rajaee, Z; Shirvalilou, S | 1 |
| Crowther, K; Hounsell, AR; Jain, S; King, RB; McGarry, CK; McGrath, C; Osman, SOS; Prise, KM; Russell, E | 1 |
| Chee, G; Fu, J; Gao, Y; Hu, P; King, C; Kishan, AU; Lewis, JH; Ruan, D; Singhrao, K; Yang, Y | 1 |
| Ghaffarinejad, A; Omidinia, E; Sabahi, A; Salahandish, R | 1 |
| Pan, Z; Ren, Z; Shao, K; She, Y; Teng, Y; Wang, Z; Zhang, Y | 1 |
| Cultrara, CN; Ramos, JA; Sabatino, D; Samuni, U; Shah, SS; Zilberberg, J | 1 |
| Man, L; Xu, X | 1 |
| Bourbonne, V; Boussion, N; Chasseray, M; Dissaux, G; Goasduff, G; Lucia, F; Pradier, O; Schick, U | 1 |
| Ahmadianpour, MV; Mowla, J; Raheb, J; Sotoodehnejadnematalahi, F | 1 |
| Althagafi, D; Basu, U; Büttner, B; Curran, D; Mc Carthy, C; Müller-Bunz, H; O'Beirne, C; Ott, I; Sánchez-Sanz, G; Sterner-Kock, A; Tacke, M; Walther, W; Zhu, X | 1 |
| Fusaro, M; Kubiszewski, M; Leś, A; Menaszek, E; Sidoryk, K; Stolarczyk, EU; Stolarczyk, K; Strzempek, W; Łaszcz, M | 1 |
| Abdollahi, M; Ganjali, MR; Hassani, S; Norouzi, P; Rahmani, SR; Rezaei Akmal, M; Salek Maghsoudi, A; Sarihi, P | 1 |
| Basilion, JP; Burda, C; Erokwu, BO; Flask, CA; Johnson, A; Li, H; Lou, J; Luo, D; Meade, TJ; Ramamurthy, G; Springer, S; Wang, X | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Bao, Y; Cai, Z; Chen, G; Chen, J; Cui, W; Hu, J; Huang, C; Li, B; Liao, X; Luo, H; Qu, Q | 1 |
| Maejima, R; Makita, C; Matsuo, M; Ono, K; Tanaka, O; Taniguchi, T; Yama, E | 1 |
| Colombatti, M; Colusso, A; Fracasso, G; Litti, L; Meneghetti, M; Pinto, M; Ruli, E; Scarsi, A; Toffoli, G; Ventura, L | 1 |
| Braz, DC; Bruno, OM; Carvalho, AL; Melendez, ME; Oliveira, ON; Reis, RM; Ribas, LC; Rodrigues, VC; Sanfelice, RC; Scabini, LFS; Soares, AC; Soares, JC | 1 |
| Adalbjörnsson, SI; Gustafsson, CJ; Jakobsson, A; Olsson, LE; Swärd, J | 1 |
| Hao, Y; Hu, J; Wang, C; Wang, H | 1 |
| Boś-Liedke, A; Kozak, M; Musielak, M; Piotrowski, I; Suchorska, W | 1 |
| Arkan, E; Behbood, L; Darvishi, E; Ehzari, H; Shahlaei, M | 1 |
| Ravi Shankaran, D; Thambiraj, S; Vijayalakshmi, R | 1 |
| Feng, L; Han, F; Lu, L; Meng, L; Min, P; Sheng, G; Wang, C; Wang, Y; Xu, H; Zhang, L; Zhang, Y | 1 |
| Abu-Dahab, R; Aqabani, H; Hikmat, S; Mahmoud, NN | 1 |
| An, J; Bock, S; Choi, Y; Hahm, E; Huynh, KH; Jeong, DH; Jun, BH; Kim, HM; Kim, J; Kim, JW; Lee, HY; Lee, S; Pham, XH; Rho, WY; Song, H | 1 |
| Chen, G; Feng, S; Lin, D; Qiu, S; Wu, Q | 1 |
| Ajdžanović, V; Barudžija, T; Filipović, B; Maksimović-Ivanić, D; Marković, MM; Mijatović, S; Milošević, V; Mojić, M; Otoničar, M; Šošić-Jurjević, B; Stamenović, U; Vodnik, VV | 1 |
| Dogan, N; Ford, JC; Hara, D; Pollack, A; Pourmand, A; Shi, J; Tao, W; Totiger, TM | 1 |
| Cai, Y; Cui, Y; Dong, C; Hui, W; Ma, T; Yang, J; Zhang, H; Zhang, S | 1 |
| Almowalad, J; Dufès, C; Laskar, P; Meewan, J; Mullin, M; Somani, S; Tate, RJ | 1 |
| Cao, X; Li, L; Lu, W; Mao, Y; Song, Q; Sun, Y | 1 |
| Al-Yasiri, AY; Hans, CP; Katti, KK; Katti, KV; Khan, A; Khoobchandani, M; Lugão, AB; MohanDoss, DKD; Nicholl, MB; Thipe, VC | 1 |
| Huang, Y; Li, S; Shi, M; Zhang, L; Zhao, J; Zhao, S | 1 |
| Chung, KH; Kim, AR; Kim, IH; Kim, KS; Kim, MS; Ko, S; Park, TJ | 1 |
| Barelkowski, T; Beck, M; Böhmer, D; Budach, V; Ghadjar, P; Graf, R; Joswig, M; Wust, P | 1 |
| Khan, R; Pal, M | 1 |
| Gunnlaugsson, A; Gustafsson, C; Korhonen, J; Nyholm, T; Olsson, LE; Persson, E | 1 |
| Chen, L; Dong, Y; Li, Y; Liu, H; Liu, Q; Wang, P; Yan, Q; Yang, Y; Zhang, D | 1 |
| Feng, JJ; Liu, WD; Wang, AJ; Wang, R; Wu, L; Xue, Y | 1 |
| de Boer, HCJ; Kerkmeijer, LGW; Lagendijk, JJW; Maspero, M; Meijer, GJ; Seevinck, PR; Sikkes, GG; van den Berg, CAT; Viergever, MA; Zijlstra, F | 1 |
| Li, K; Lu, L; Ma, B; Mao, YH; Qu, H; Wang, ZY; Yao, B; Zhong, WW | 1 |
| Heli, H; Rahi, A; Sattarahmady, N | 2 |
| Castro, GR; Crulhas, BP; Delella, FK; Karpik, AE; Pedrosa, VA | 1 |
| Hema, S; Shankaran, DR; Thambiraj, S | 1 |
| Fujimoto, S; Hirose, S; Komeda, H; Matsuo, M; Seike, K; Tamaki, M; Tanaka, O; Yama, E | 1 |
| Hua, H; Li, S; Liu, D; Liu, T; Song, L; Zhang, N; Zhao, Y | 1 |
| Ji, S; Kim, D; Lee, M | 1 |
| Chen, Y; Deng, S; Ma, L; Meng, J; Wang, S; Xu, LP; Zhang, S; Zhang, X | 1 |
| Hirose, S; Komeda, H; Matsuo, M; Ono, K; Tanaka, O; Taniguchi, T | 1 |
| Bertorelle, F; Colombatti, M; Conti, G; Fiameni, S; Fracasso, G; Gobbo, M; Litti, L; Meneghetti, M; Pilot, R; Pinto, M; Toffoli, G; Zappon, R | 1 |
| Ahmed, MF; Aliru, M; Aziz, K; Bodd, M; Cho, J; Cho, SH; Khoo, AM; Krishnan, S; Manohar, N; Reynoso, FJ; Tailor, R; Thames, HD; Yang, X; Yasar, S | 1 |
| Nirala, NR; Prakash, R; Srivastava, M; Srivastava, SK | 1 |
| Han, L; Liu, A; Petrenko, VA; Xia, H; Yin, L | 1 |
| Beaulieu, L; Côté, MF; Fortin, MA; Lagueux, J; Laprise-Pelletier, M; Ma, Y | 1 |
| Brahman, PK; J S, B; Reddy, KR; Suresh, L | 1 |
| Hien, A; Pretze, M; Rädle, M; Schirrmacher, R; Wängler, B; Wängler, C | 1 |
| Li, W; Ma, Z; Zhang, D | 1 |
| Joon, P; Kumar, P; Narwal, V; Pundir, CS | 1 |
| Basilion, JP; Burda, C; Escamilla, M; Govande, M; Mangadlao, JD; McCleese, C; Ramamurthy, G; Wang, X; Wang, Z | 1 |
| Jung, MY; Lee, J; Park, HJ | 1 |
| Deng, D; Fang, C; Li, SJ; Wang, Y; Xia, N | 1 |
| de Boer, HCJ; de Kogel, GJ; Maspero, M; Seevinck, PR; Sikkes, GG; van den Berg, CAT; van der Voort van Zyp, JRN; Willems, NJW | 1 |
| Abou-Hassan, A; Alvarez-Lorenzo, C; Botton, GA; Bugnet, M; Cabana, S; Curcio, A; Espinosa, A; Kolosnjaj-Tabi, J; Péchoux, C; Radtke, G; Silva, AKA; Wilhelm, C | 1 |
| Chu, J; Liu, X; Wang, D; Wang, W; Xu, Y | 1 |
| Chen, G; Cui, K; Fan, C; Han, A; Li, M; Qiu, Y; Wan, JB; Xiao, Z; Ye, J; Zhang, Y | 1 |
| Wang, D; Wang, Y; Yang, S; Yang, W; Yao, D; Zhang, B | 1 |
| Jaiwal, R; Kumar, P; Narwal, V; Pundir, CS | 1 |
| Andras, I; Couti, R; Crisan, D; Crisan, N; Leopold, N; Moisoiu, V; Pavel, IE; Rahota, R; Socaciu, C; Stefancu, A | 1 |
| Calarco, A; Musto, P; Pannico, M; Peluso, G | 1 |
| Gunnlaugsson, A; Gustafsson, C; Olsson, LE; Persson, E | 1 |
| Eiamphungporn, W; Htoo, KPP; Suksrichavalit, T; Viseshsindh, W; Yainoy, S; Yamkamon, V | 1 |
| Giannakos, G; Kalogeropoulou, K; Kintzios, S; Mavrikou, S; Moschopoulou, G; Skevis, A; Zafeirakis, A | 1 |
| Abarghoei, S; Borghei, YS; Fakhri, N; Ganjali, MR; Hosseini, M | 1 |
| de-Los-Santos-Álvarez, N; Díaz-Fernández, A; Lobo-Castañón, MJ; Miranda-Castro, R; Rodríguez, EF | 1 |
| Chen, M; Cheng, Q; Cheng, Y; Feng, Q; Huang, L; Liang, F; Pan, J; Qin, Y; Shi, Y; Wang, Y; Wen, X; Xu, C; Xu, P | 1 |
| Chen, N; Chen, Z; Dong, B; Kang, X; Liu, S; Pan, J; Shao, X; Wang, Y; Xue, W; Zhu, Y | 1 |
| Chen, J; Fu, B; Li, K; Liu, T | 1 |
| Cong, Z; Guo, J; He, Y; Holmes, JD; Luan, X; O'Driscoll, CM; Rahme, K; Wang, L; Yang, H; Zou, Y | 1 |
| Bella, V; Bertok, T; Eckstein, AA; Gajdosova, V; Hires, M; Hroncekova, S; Jane, E; Kaman, O; Kasak, P; Lorencova, L; Mosnacek, J; Sokol, R; Tkac, J; Vikartovska, A | 1 |
| Ghanem, E; Rahme, K; Sarkis, M | 1 |
| Abbas, MN; Ben Ali, M; Dempsey, E; Fredj, Z | 1 |
| Cheng, C; Ding, M; Huang, Q; Huang, W; Li, J; Shi, Q; Yang, X; Zhong, S; Zhu, H; Zhu, LG; Zou, Y | 1 |
| McNabb, E; Noseworthy, MD; Wong, R | 1 |
| Chen, X; Gao, Y; Hao, M; Jiang, J; Kong, C; Li, J; Wang, Y; Yang, B; Zhang, H; Zhao, X | 1 |
| Farzin, L; Sadjadi, S; Shamsipur, M; Sheibani, S | 1 |
| Guo, J; Holmes, JD; Rahme, K | 1 |
| Gill, AAS; Karpoormath, R; Nlooto, M; Singh, S | 1 |
| Di, W; Ding, L; Duan, YR; Sun, Y; Wang, L; Wang, Q; Zhang, X; Zhu, WH | 1 |
| Chang, N; Chen, R; Dong, J; Ge, Q; Liu, B; Luan, C; Ni, H; Zhao, X | 1 |
| Basilion, JP; Burda, C; Luo, D; Ramamurthy, G; Wang, X; Zeng, S | 1 |
| Bartels, LW; Beld, E; Kerkmeijer, LGW; Lagendijk, JJW; Mandija, S; Moonen, CTW; Seevinck, PR; Shcherbakova, Y; van den Berg, CAT; van der Voort van Zyp, JRN | 1 |
| Cho, SW; Kim, AR; Kim, DI; Lee, JY; Shin, SW; Um, SH | 1 |
| Bischof, JC; Choi, J; Griffin, RJ; Iltis, I; Koonce, NA; Metzger, GJ; Shenoi, MM | 1 |
| de Klerk, N; Fritschi, L; Musk, AW; Peters, S; Reid, A | 1 |
| Donker, R; Kiemeney, LA; Langenhuijsen, JF; McColl, GM; van Lin, EN; Witjes, JA | 1 |
| Chapet, O; Colombel, M; De Bari, B; Devonec, M; Jalade, P; Michel-Amadry, G; Rouvière, O; Ruffion, A; Udrescu, C | 1 |
| Amanie, J; Bédard, EL; Moore, RB; Pervez, N; Razzak, R; Roa, WH; Shaw, A; Yang, X; Zhou, J | 1 |
| Altman, MB; Chen, T; Huang, CZ; Sefah, K; Tan, W; Wang, J; You, M; Zhao, Z | 1 |
| De Pauw, E; De Pauw-Gillet, MC; Fleron, M; Frenz, M; Greisch, JF; Jaeger, M; Schol, D | 1 |
| Chen, W; Feng, R; Ma, L; Maley, J; Sammynaiken, R; Xiang, G; Yang, C | 1 |
| Chen, G; Liu, B; Tang, D; Zhang, B | 1 |
| Ålander, E; Keyriläinen, J; Kouri, M; Saarilahti, K; Tenhunen, M; Visapää, H | 1 |
| Demeritte, T; Duan, J; Fan, Z; Pachter, R; Ray, PC; Sinha, SS | 1 |
| Duan, XL; Han, L; Li, LH; Liang, XJ; Liu, J; Wei, XF; Wei, Y; Zhao, J | 1 |
| Butterworth, KT; Coulter, JA; Currell, FJ; Dickson, GR; Hirst, DG; Hounsell, AR; Hyland, WB; Jain, S; McMahon, SJ; Muir, MF; O'Sullivan, JM; Prise, KM | 2 |
| Buckway, B; Frazier, N; Ghandehari, H; Gormley, AJ; Ray, A | 1 |
| Beauchemin, MC; Béliveau-Nadeau, D; Carrier, JF; Delouya, G; Fortin, I; Taussky, D | 1 |
| Braun, GB; Huang, X; Morales, DP; Ogunyankin, MO; Pallaoro, A; Reich, NO; Zasadzinski, J | 1 |
| Han, L; Huo, S; Ji, T; Jin, S; Kumar, A; Li, S; Liang, XJ; Liu, H; Liu, J; Tan, A; Tang, S; Wang, T; Xue, X; Zhang, J; Zhang, X; Zhao, Y; Zou, G | 1 |
| Coelho, MA; Coelho, SC; Juzenas, P; Pereira, MC; Rocha, S | 1 |
| Bordegaray, M; Kably, I; Narayanan, G; Salsamendi, J; Shah, K | 1 |
| Chen, S; Deng, C; Jiang, Z; Peng, Z; Qin, Y; Xiang, J | 1 |
| Manuchehrabadi, N; Zhu, L | 1 |
| Detering, L; Liu, Y; Luehmann, H; Sultan, D; Zhao, Y | 1 |
| Chen, HY; Liu, J; Lu, CY; Xu, JJ; Zhou, H | 1 |
| Axiak-Bechtel, SM; Boote, E; Bryan, JN; Bryan, ME; Cutler, CS; Henry, CJ; Kannan, R; Katti, KV; Kelsey, J; Lattimer, JC; Selting, KA; Tate, DJ; Upendran, A | 1 |
| Ju, H; Ren, K; Wu, J; Yan, F; Zhang, Y | 1 |
| Dong, C; Huang, X; Lan, T; Ren, J; Wang, J | 1 |
| Drnevich, J; Falagan-Lotsch, P; Grzincic, EM; Murphy, CJ; Yang, JA | 1 |
| Deloar, HM; Gehrke, C; Gill, S; Kron, T; Oates, R; Ramachandran, P | 1 |
| Bhattarai, S; Chatterjee, D; Goodrich, G; Grant, JD; Krishnan, S; Lee, J; Nicolucci, P; Tailor, R; Wolfe, T | 1 |
| Araki, H; Fukasawa, S; Hara, R; Hatano, K; Ichikawa, T; Imagumbai, T; Kobayashi, M; Komaru, A; Namekawa, T; Ueda, T | 1 |
| Bai, L; Chen, F; Chen, J; Dong, Q; Hu, Q; Ma, Z; Shen, Y | 1 |
| Almodovar, AJ; Chen, S; Decker, DD; Griffith, E; Huo, Q; Pierre-Pierre, N; Rivera-Ramirez, I; Valerio, F; Yan, X; Zheng, T; Zhu, N | 1 |
| Belmonte, P; Bonifacio, A; Cervo, S; Colombatti, A; Del Mistro, G; Mansutti, E; Sergo, V; Spizzo, R; Steffan, A; Zucconelli, R | 1 |
| Hong, S; Jang, J; Sharma, A; Singh, R | 1 |
| Reznikov, AG; Salivonyk, OA; Shuba, YM; Sotkis, AG | 1 |
| Hallaj, R; Kavosi, B; Moradi, F; Salimi, A | 1 |
| Bezak, E; Douglass, M; Kempson, I; Paterson, D; Thierry, B; Turnbull, T | 1 |
| Chung, FM; Houng, JY; Hu, JJ; Hung, WC; Lee, YJ; Lin, HY; Lu, LF; Wang, CP; Wu, CC; Yu, TH | 1 |
| Arm, J; Best, L; Chandra, SS; Dowling, JA; Fripp, J; Ghose, S; Greer, PB; Martin, J; Menk, FW; Pichler, P; Richardson, H; Rivest-Hénault, D; Sun, J; Wratten, C | 1 |
| Archambault, L; Cantin, A; Foster, W; Gingras, L; Goudreault, J; Lachance, B | 1 |
| Asadi, S; Knaup, C; Masoudi, SF; Meigooni, AS; Rahmani, F; Vaez-zadeh, M | 1 |
| Berthuy, OI; Blum, LJ; Marquette, CA | 1 |
| Christensen, P; Hao, Y; Hassan, G; Jiang, R; Moeendarbari, S; Mulgaonkar, A; Öz, OK; Ramezani, S; Sun, X; Tekade, R | 1 |
| Chan, WC; Chen, J; Cramb, DT; Dai, Q; Hwang, DM; Rinker, KD; Rocheleau, JV; Sarsons, CD; Sykes, EA; Zheng, G | 1 |
| Cho, SH; Diagaradjane, P; Krishnan, S; Manohar, N; Reynoso, FJ | 1 |
| Desboeufs, K; Espinosa, A; Grzelczak, M; Liz-Marzán, LM; Péchoux, C; Sánchez-Iglesias, A; Silva, AK; Wilhelm, C | 1 |
| Brégier, F; Chaleix, V; Granet, R; Leger, DY; Liagre, B; Mbakidi, JP; Micallef, L; Pouget, C; Qiu, S; Sol, V; Sothea-Ouk, T | 1 |
| Joseph, MM; Karunakaran, V; Maiti, KK; Nair, JB; Narayanan, N; Ramya, AN | 1 |
| Deming, TJ; Dern, KR; Ding, K; Grundfest, WS; Kamei, DT; Mayle, KM; Rodriguez, AR; Sung, S; Taylor, Z; Wong, VK; Zhou, ZH | 1 |
| Dowling, JA; Fazlollahi, A; Fripp, J; Ghose, S; Greer, PB; Mitra, J; Pichler, P; Rivest-Hénault, D; Stanwell, P; Sun, J | 1 |
| Guo, J; Holmes, JD; O'Driscoll, CM; Rahme, K | 1 |
| Carrascosa, LG; Koo, KM; Shiddiky, MJ; Trau, M | 1 |
| Bazzi, R; Butterworth, KT; Chaudhary, P; Coulter, JA; Ghita, M; Jimenez-Sanchez, G; McCarthy, HO; McGarry, CK; Nicol, JR; Prise, KM; Rosa, S; Roux, S; Tillement, O | 1 |
| Goldstein, J; Lawrence, YR; Saad, A; Saad, R; Spieler, B; Symon, Z; Weiss, I | 1 |
| Cho, S; Kim, DH; Larson, AC; Procissi, D; Zhao, K | 1 |
| Hua, H; Huang, W; Li, S; Liu, D; Song, L; Sun, P; Tang, Y; Zhang, N; Zhao, Y | 1 |
| Chen, KY; Deming, TJ; Dern, KR; Ding, K; Grundfest, WS; Kamei, DT; Knowles, S; Mayle, KM; Rodriguez, AR; Sung, S; Taylor, Z; Wong, VK; Wu, AM; Zhou, ZH | 1 |
| Beloglazkina, EK; Garanina, AS; Kotelyanskii, VE; Machulkin, AE; Mazhuga, AG; Savchenko, AG; Zhironkina, OA; Zyk, NV | 1 |
| Yeo, WS; Yoo, M | 1 |
| Amani, H; Avan, A; Ferns, GA; Jazayeri, MH; Pazoki-Toroudi, H; Pourfatollah, AA | 1 |
| Avvakumova, S; Chirico, G; Collini, M; Colombo, M; Corsi, F; Galbiati, E; Gambini, L; Locarno, SA; Macchi, C; Magni, P; Pandolfi, L; Prosperi, D; Romeo, S; Ruscica, M; Sironi, L | 1 |
| Arion, S; Caraivan, I; Chapet, O; Enachescu, C; Rouviere, O; Shakir, SI; Udrescu, C | 1 |
| Corde, S; Guatelli, S; Incerti, S; Ivanchenko, V; Konstantinov, K; Lerch, M; McKinnon, S; Rosenfeld, A; Tehei, M | 1 |
| Allender, CJ; Bhalla, N; Bowen, CR; Bowen, JL; Estrela, P; Jolly, P; Tamboli, VK; Taylor, JT | 1 |
| Ahmed, HU; Allen, C; Barratt, D; Georgiou, PS; Gibson, E; Jaros, J; Payne, H; Shah, TT; Treeby, BE | 1 |
| Kim, K; Kim, N; Kim, SH; Kwon, IC; Son, S; Yhee, JY; Yoon, HY; You, DG | 1 |
| Chavva, SR; Jones, S; Matthew, T; May, K; Pramanik, A; Ray, PC; Vangara, A; Viraka Nellore, BP | 1 |
| Côté, MF; Fortin, MA; LaGrange, T; Lagueux, J; Laprise-Pelletier, M | 1 |
| Habibi, S; Liu, Y; Nie, Z; Tao, J; Xia, X; Yang, K; Ye, H; Zhang, Q | 1 |
| Brivio, D; Nguyen, PL; Ngwa, W; Sajo, E; Zygmanski, P | 1 |
| Ágoston, P; Jorgo, K; Major, T; Polgár, C; Takácsi-Nagy, Z | 1 |
| Hankins, JD; Liu, L; Sun, S; Sun, X; Yu, M; Zhang, S; Zheng, J; Zhou, C | 1 |
| Amanie, J; Chen, J; Gulavita, S; Ko, L; Moore, R; Pervez, N; Roa, W; Xing, JZ; Yee, D; Zhang, X | 1 |
| Lee, JB; Lee, SB; Namgung, M; Oh, SY | 1 |
| Cox, J; Cramb, J; Duchesne, G; Foroudi, F; Kron, T; Owen, R; Sparks, L; Zhu, L | 1 |
| Foroudi, F; Fox, C; Laferlita, M; Owen, R; Styles, C; Tai, KH; Thompson, A | 1 |
| Louwe, RJ; Spitters-Post, I; van der Vight, LP; van Lin, EN; Visser, AG | 1 |
| Barnett, R; Fleming, K; Jiang, R; Osei, EK; Panjwani, D | 1 |
| Kruger, AE; Lips, IM; van der Heide, UA; van Gils, CH; van Vulpen, M | 1 |
| Budiharto, T; Depuydt, T; Haustermans, K; Hermans, J; Heuvel, FV; Maes, F; Oyen, R; Slagmolen, P; Verstraete, J | 1 |
| Béliveau-Nadeau, D; Carrier, JF; Fortin, B; Gauthier, I; Taussky, D | 1 |
| Balter, P; Ciangaru, G; Fontenot, J; Giebeler, A; Newhauser, W; Zhu, R | 1 |
| Chanda, N; Kannan, R; Katti, KV; Shukla, R | 1 |
| Amos, RA; Dong, L; Johnson, JL; Kudchadker, RJ; Lee, AK; Nakanishi, H; Ochiai, A; Yu, ZH; Zhang, L; Zhang, Y | 1 |
| Bel, A; Kotte, AN; Lips, IM; van der Heide, UA; van Vulpen, M | 1 |
| Cleeve, L; Cox, J; Cramb, J; Duchesne, G; Foroudi, F; Kron, T; Laferlita, M; Milner, A; Owen, R; Sparks, L; Zhu, L | 1 |
| Agaçayak, F; Akpinar, H; Alço, G; Igdem, S; Okkan, S; Turkan, S | 1 |
| Adamson, J; Wu, Q | 1 |
| Ahn, SH; Cho, KH; Kim, DW; Kim, DY; Kim, JS; Kwak, J; Lee, SB; Lim, YK; Park, S; Park, SY; Pyo, HR; Shin, D; Shin, J; Yoon, M | 1 |
| Agustin, J; Bunyapanasarn, J; Chittenden, L; Lizarde, J; Mesa, AV; Ravera, J; Tokita, KM; Wilder, RB | 1 |
| Garnica-Garza, HM | 1 |
| Chen, J; Gulavita, S; Guo, L; Hu, X; Moore, R; Patel, S; Roa, W; Shaw, A; Sun, X; Xing, JZ; Xiong, Y; Zhang, X | 1 |
| Hyun, J; Jung, J; Kim, KW; Lee, J; Na, K | 1 |
| Hsu, A; King, C; Lee, L; Luxton, G; Mao, W; Riaz, N; Solberg, T; Wiersma, R; Xing, L | 1 |
| Aebersold, DM; Behrensmeier, F; Ghadjar, P; Gwerder, N; Madlung, A; Mini, R; Thalmann, GN | 1 |
| Ghandehari, H; Malugin, A | 1 |
| de la Escosura-Muñiz, A; Díaz-Freitas, B; González-Fernández, A; Maltez-da Costa, M; Merkoçi, A; Sánchez-Espinel, C | 1 |
| Hearty, S; Leonard, P; O'Kennedy, R | 1 |
| Heys, JJ; Huang, HC; Rege, K | 1 |
| Huo, Q | 1 |
| Liu, W; Wiersma, RD; Xing, L | 1 |
| Jeong, YY; Jon, S; Kim, D | 1 |
| Delk, NA; Farach-Carson, MC; Hafner, JH; Lapotko, DO; Lukianova-Hleb, EY; Wagner, DS | 1 |
| Adamson, J; Wu, Q; Yan, D | 1 |
| Assendelft, E; de Reijke, TM; Haverkort, MA; Koning, CC; Lensing, AL; Pieters, BR; Stoker, J; van de Kamer, JB; van Herk, M; van Tienhoven, G | 1 |
| Ahmad, B; Bauman, G; Best, L; D'Souza, D; Izawa, J; Lock, M; Rodrigues, G; Sexton, T; Venkatesan, V; Wong, E | 1 |
| Bhattacharyyal, K; Boote, E; Dale, PS; Goldschmidt, BS; Gupta, S; Kannan, R; Katti, K; Shukla, R; Viator, JA | 1 |
| Catton, CN; de Bois, J; Jaffray, DA; Lebesque, JV; Smitsmans, MH; Sonke, JJ; van Herk, M | 1 |
| Khan, SA; Lu, W; Ray, PC; Senapati, D; Singh, AK; Yu, H | 1 |
| Beresford, R; Jaroenapibal, P; Shi, H; Triroj, N; Yeh, JI | 1 |
| Camacho-López, MA; De León-Rodríguez, LM; de M Ramírez, F; Ferro-Flores, G; Medina, LA; Mendoza-Sánchez, AN; Morales-Avila, E; Ocampo-García, BE; Rojas-Calderón, EL; Santos-Cuevas, CL | 1 |
| Gao, X; Hu, X | 1 |
| Garpebring, A; Jonsson, JH; Karlsson, MG; Nyholm, T | 1 |
| Li, J; Liu, Y; Wang, T; Xu, S | 1 |
| Huang, HC; Koria, P; Nanda, A; Rege, K; Yang, Y | 1 |
| Baker, CH; Bogdanovic, J; Colon, J; Cordero, A; Goodison, S; Huo, Q; Pensky, MY | 1 |
| Nishioka, K; Onimaru, R; Osaka, Y; Sazawa, A; Shimizu, S; Shinohara, N; Shirato, H; Suzuki, R | 1 |
| Beqa, L; Demeritte, T; Fan, Z; Khan, SA; Lu, W; Ray, PC; Senapati, D; Senapati, T; Singh, AK | 1 |
| Grabtchak, S; Palmer, TJ; Whelan, WM | 1 |
| Brown, S; Burmeister, E; Ferrari-Anderson, J; Glyde, A; Lehman, M; Nicol, D | 1 |
| Gates, LL; Gladstone, DJ; Hartford, AC; Hug, E; Kasibhatla, MS; Marshall, JF; Seigne, JD | 1 |
| Kaanders, JH; Langenhuijsen, JF; Louwe, RJ; Smeenk, RJ; van Kollenburg, P; van Lin, EN; Witjes, JA | 1 |
| De Gersem, W; De Meerleer, G; De Wagter, C; Fonteyne, V; Impens, A; Oosterlinck, W; Ost, P; Villeirs, G | 1 |
| de Boer, HC; Dirkx, ML; Heijmen, BJ; Incrocci, L; Mutanga, TF; Rajan, V | 1 |
| Ghandehari, H; Gormley, AJ; Malugin, A; Ray, A; Robinson, R | 1 |
| Elliott, AM; Goodrich, GP; Hazle, JD; Schwartz, JA; Shetty, A; Stafford, RJ | 1 |
| Diller, KR; Hazle, J; Rylander, MN; Stafford, RJ; Whitney, J | 1 |
| Bayley, A; Bristow, RG; Catton, C; Chung, P; Gospodarowicz, M; Jacks, L; Lockwood, G; Ménard, C; Milosevic, M; Nichol, A; Rosewall, T; Skala, M; Vesprini, D; Warde, P | 1 |
| Belard, A; Chen, Y; Ko, CJ; Mayer, RR; McDonough, JE; O'Connell, JJ | 1 |
| Deutschmann, H; Fastner, G; Forstner, R; Gaisberger, C; Jeschke, S; Kametriser, G; Mitterlechner, B; Mooslechner, M; Scherer, P; Schöller, H; Sedlmayer, F; Steininger, P; Weichenberger, H; Wurstbauer, K | 1 |
| Cheung, PC; Deabreu, A; Holden, L; Loblaw, DA; Mamedov, A; Morton, G; Pang, G; Quon, H; Tang, C | 1 |
| Buyyounouski, MK; Chen, L; Hossain, M; Ma, CM; Richardson, T; Schirmer, T | 1 |
| Jansa, J; Kasaová, L; Paluska, P; Petera, J; Sirák, I | 1 |
| Kim, BW; Sim, SJ; Truong, PL | 1 |
| Chen, HY; Dong, XY; Kong, FY; Wang, J; Xu, JJ; Zhao, WW | 1 |
| Cho, B; Fledelius, W; Keall, P; Poulsen, PR | 1 |
| Decker, DA; Hallquist, H; Huo, Q; Litherland, SA; Rivera-Ramirez, I; Sullivan, S | 1 |
| Alhasan, AH; Daniel, WL; Kim, DY; Meeks, JJ; Mirkin, CA; Thaxton, CS; Watson, E | 1 |
| Beauchemin, MC; Béliveau-Nadeau, D; Carrier, JF; Nguyen, TV; Taussky, D; Tiberi, DA | 1 |
| Beqa, L; Fan, Z; Kanchanapally, R; Khan, SA; Ray, PC; Senapati, D; Singh, AK | 1 |
| Cui, Y; Huan, Y; Larson, AC; Liu, Y; Ren, J; Wang, F; Wei, G; Yang, A; Yang, Y; Zhang, R; Zhang, Z | 1 |
| Budiharto, T; Corn, BW; Davits, RJ; de Kruijf, WJ; Haustermans, K; Hol, S; Neustadter, D; Oyen, R; Poortmans, PM; Van den Bergh, L; Venselaar, JL; Verstraete, J; Wijsman, BP | 1 |
| Butterworth, KT; Coulter, JA; Currell, FJ; Dickson, GR; Hirst, DG; Hounsell, AR; Hyland, WB; Jain, S; McMahon, SJ; Muir, MF; O'Sullivan, JM; Prise, KM; Schettino, G; Taggart, LE; Trainor, C | 1 |
| Huan, Y; Larson, AC; Liu, Y; Ren, J; Wang, F; Wei, G; Wei, M; Yang, Y; Zhang, Z | 1 |
| Austin, LA; Dreaden, EC; El-Sayed, MA; Gryder, BE; Hayden, SC; Oyelere, AK; Pi, M; Quarles, LD; Tene Defo, BA | 1 |
| Boote, E; Caldwell, C; Carmack, TL; Casteel, SW; Chanda, N; Cutler, CS; Engelbrecht, H; Kan, P; Kannan, R; Katti, K; Katti, KV; Kulkarni, RR; Lever, JR; Nune, SK; Robertson, JD; Shukla, R; Smith, CJ; Upendran, A; Vimal, J; Watkinson, LD; Zambre, A | 1 |
| Barchi, JJ; Brinãs, RP; Deng, W; Morey, S; Rittenhouse-Olson, K; Sahoo, P; Sundgren, A; Wilding, GE | 1 |
| Amendola, V; Boscaini, A; Colombatti, M; Di Chio, M; Fracasso, G; Gobbo, M; Litti, L; Marcolongo, G; Meneghetti, M; Scarsi, A | 1 |
| Bachaud, JM; Beckendorf, V; Bossi, A; Chapet, O; Chauvet, B; Créhange, G; de Crevoisier, R; Dudouet, P; Lagrange, JL; Laplanche, A; Latorzeff, I; Mahé, MA; Morelle, M; Muracciole, X; Nguyen, TD; Perrier, L; Pommier, P; Supiot, S; Touboul, E; Zawadi, A | 1 |
| Chai, Y; Han, J; Yuan, R; Zhang, W; Zhu, Q; Zhuo, Y | 1 |
| de Boer, J; de Bois, J; Sonke, JJ; van Herk, M | 1 |
| Capp, A; Denham, JW; Greer, PB; Parker, J; Patterson, J; Singh, J; Tang, CI; White, MA; Wratten, C | 1 |
| Haverkort, MA; Koning, CC; Pieters, BR; van de Kamer, JB; van Herk, M; van Tienhoven, G | 1 |
| Benny, PD; Berkman, CE; Kasten, BB; Liu, T; Nedrow-Byers, JR | 1 |
| Fathi, F; Hallaj, R; Kavosi, B; Salimi, A | 1 |
| Bhimji, A; Kelley, SO; Moscovici, M | 1 |
| Dosaka-Akita, H; Endo, H; Harabayashi, T; Harada, T; Hida, K; Kitamura, K; Kurauchi, N; Matsushita, M; Miyasaka, K; Onimaru, R; Shimizu, T; Shinohara, N; Shirato, H; Yamazaki, K | 1 |
| Aubin, M; Langen, KM; Liu, YM; Pickett, B; Pouliot, J; Roach, M; Shinohara, K | 1 |
| Dehnad, H; Hofman, P; Lagendijk, JJ; Nederveen, AJ; van der Heide, UA; van Moorselaar, RJ | 1 |
| Davis, BJ; Herman, MG; King, BF; Kruse, JJ; Pisansky, TM; Prisciandaro, JI | 1 |
| Forman, JD; Khan, M; Littrupp, P; Powell, T; Seppi, E; Van den Heuvel, F; Wang, Y | 1 |
| CULP, D; ELKINS, HB; FLOCKS, RH; KERR, HD | 1 |
| Aubin, M; Millender, LE; Pouliot, J; Roach, M; Shinohara, K | 1 |
| Inui, M; Kakehi, Y; Kuwata, Y; Mitani, M; Shimada, O; Takashima, H; Taketa, S; Tsukuda, F | 1 |
| Barentsz, JO; Fütterer, JJ; Huisman, HJ; Scheenen, TW; van Dalen, JA; van Lin, EN; Visser, AG; Welmers, A; Witjes, JA | 1 |
| Balter, JM; Lam, KL; Litzenberg, DW; Sandler, HM; Ten Haken, RK | 1 |
| Herman, MG; Kruse, JJ; Pisansky, TM; Schallenkamp, JM | 1 |
| Balter, JM; Hadley, SW; Kupelian, PA; Levine, L; Litzenberg, DW; Sandler, HM; Willoughby, TR | 1 |
| Lebesque, JV; Lockman, D; Yan, D | 1 |
| Forman, JD; Fugazzi, J; Seppi, E; Van den Heuvel, F | 1 |
| Barentsz, JO; Fütterer, JJ; Heijmink, SW; Hoffmann, AL; Huisman, HJ; Leer, JW; Scheenen, TW; van der Vight, LP; van Kollenburg, P; van Lin, EN; Visser, AG; Witjes, JA | 1 |
| Aebersold, DM; Behrensmeier, F; Born, EJ; Greiner, RH; Kemmerling, L; Mini, R; Thalmann, S; Vetterli, D | 1 |
| Coffey, J; Dearnaley, DP; Hansen, VN; Mangar, SA; McNair, HA; Norman, A; Shoulders, B; Sohaib, SA; Staffurth, J; Warrington, AP | 1 |
| Buskirk, SJ; Earle, JD; Gale, AA; Igel, TC; Serago, CF; Serago, NE | 1 |
| Brock, KK; Catton, CN; Jaffray, DA; Lockwood, GA; Moseley, DJ; Nichol, AM; Rosewall, T; Warde, PR | 1 |
| Dehnad, H; Hofman, P; Kotte, AN; Lagenijk, JJ; van der Heide, UA; van Vulpen, M | 1 |
| Aubin, M; Gottschalk, AR; Hsu, IC; Lometti, M; Pouliot, J; Roach, M; Schiffner, DC; Shinohara, K; Speight, J | 1 |
| Chow, JC; Grigorov, GN | 1 |
| Bissonnette, JP; Catton, CN; Gospodarowicz, M; Jaffray, DA; Moseley, DJ; Rosewall, T; Sharpe, MB; Siewerdsen, JH; Warde, P; White, EA; Wiltshire, KL | 1 |
| Kiemeney, LA; Langenhuijsen, JF; McColl, GM; van der Vight, LP; van Lin, EN; Visser, AG; Witjes, JA | 1 |
| Hofman, P; Kotte, AN; Lagendijk, JJ; van der Heide, UA; van Vulpen, M | 1 |
| Brock, KK; Chung, PW; Haider, MA; Hensel, JM; Kirilova, A; Ménard, C; Milosevic, MF; Moseley, JL | 1 |
| Cadeddu, JA; Hsieh, JT; Lotan, Y; Park, S; Stanfield, J; Stern, JM | 1 |
| Alonso-Arrizabalaga, S; Brualla González, L; García Hernández, T; López Torrecilla, J; Pastor Peidro, J; Planes Meseguer, D; Roselló Ferrando, JV | 1 |
| Beltran, C; Davis, BJ; Herman, MG | 1 |
| Balogh, L; Bolton, B; El-Jawahri, A; Hutson, A; Kariapper, MS; Khan, MK; Lesniak, W; Llanes, M; Mamou, F; Minc, L; Nair, BM; Nigavekar, SS; Sung, LY; Tan, W; Zhang, C | 1 |
| 'Aho, T; Benson, RJ; Burnet, NG; Fairfoul, J; Hoole, AC; Rimmer, YL; Routsis, DS; Treeby, J; Twyman, N; Vowler, SL; Welford, D | 1 |
| Dearnaley, DP; Del-Acroix, L; Evans, PM; Hansen, VN; Harris, EJ; Keane, R; Khoo, VS; McNair, HA; Miles, E; Norman, A; Parker, CC; Smith, E; Thompson, AC | 1 |
| Cadeddu, JA; Hsieh, JT; Kabbani, W; Stanfield, J; Stern, JM | 1 |
| Demchenko, AV; Shulga, OV; Stine, KJ; Zhou, D | 1 |
| Roach, M; Shinohara, K | 1 |
| Bociek, G; Broader, M; Crook, J; Dahrouge, S; Donker, R; Gerig, L; Malone, S; Szanto, J | 1 |
| Blake, CC; Downey, DB; Elliot, TL; Fenster, A; Slomka, PJ | 1 |
| Hofman, P; Lagendijk, JJ; Nederveen, AJ | 1 |
| Alexander, RB; Barrack, ER; Isaacs, WB | 1 |
| Gleason, DF; Sinha, AA; Wilson, MJ | 1 |
| Murphy, DJ; Porter, AT | 1 |
7 review(s) available for gold and Prostatic Neoplasms
| Article | Year |
|---|---|
Focal therapy for prostate cancer: Making the punishment fit the crime.
Topics: Crime; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Punishment; Quality of Life | 2021 |
Advances in nanomaterial-based immunosensors for prostate cancer screening.
Topics: Biomarkers; Biosensing Techniques; Copper; Early Detection of Cancer; Electrochemical Techniques; Gold; Humans; Immunoassay; Male; Nanostructures; Prostate-Specific Antigen; Prostatic Neoplasms; Silver | 2022 |
Does particle radiation have superior radiobiological advantages for prostate cancer cells? A systematic review of in vitro studies.
Topics: Carbon; DNA Repair Enzymes; Dose-Response Relationship, Radiation; Gold; Humans; Male; Metal Nanoparticles; Oxygen; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Protons | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer.
Topics: Chemoprevention; Drug Delivery Systems; Early Detection of Cancer; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2018 |
Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer.
Topics: Animals; Gold; Humans; Male; Nanostructures; Nanotechnology; Prostatic Neoplasms; Theranostic Nanomedicine | 2019 |
Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors.
Topics: Biomarkers, Tumor; Biosensing Techniques; Gold; Graphite; Humans; Male; Metal Nanoparticles; Nanotubes, Carbon; Prostatic Neoplasms | 2019 |
12 trial(s) available for gold and Prostatic Neoplasms
| Article | Year |
|---|---|
Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers.
Topics: Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Planning and implementing an implanted fiducial programme for prostate cancer radiation therapy.
Topics: Contrast Media; Gold; Humans; Image Enhancement; Male; Prostatic Neoplasms; Radiotherapy, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate.
Topics: Adenocarcinoma; Gold; Humans; Male; Movement; Posture; Prospective Studies; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2009 |
A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer.
Topics: Aged; Aged, 80 and over; Anal Canal; Diarrhea; Dose Fractionation, Radiation; Fiducial Markers; Follow-Up Studies; Gold; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Seminal Vesicles; Tumor Burden; Ultrasonography, Interventional; Urinary Bladder; Urination Disorders | 2011 |
Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cone-Beam Computed Tomography; Feasibility Studies; Fiducial Markers; Gold; Humans; Male; Middle Aged; Organs at Risk; Pain Measurement; Patient Positioning; Prostatic Neoplasms; Prostatitis; Prosthesis Implantation; Radiotherapy Dosage; Reproducibility of Results; Smoking; Ultrasonography, Interventional | 2012 |
Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment.
Topics: Dose Fractionation, Radiation; Fiducial Markers; Gold; Humans; Male; Movement; Netherlands; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy Setup Errors; Radiotherapy, Intensity-Modulated; Reproducibility of Results; Retrospective Studies; Supine Position; Time Factors | 2012 |
Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging.
Topics: Fiducial Markers; Gold; Humans; Male; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Ultrasonography | 2012 |
Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluation.
Topics: Fiducial Markers; Gold; Humans; Iridium Radioisotopes; Male; Movement; Patient Positioning; Prostatic Neoplasms; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2013 |
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment].
Topics: Adenocarcinoma; Aged; Cone-Beam Computed Tomography; Cost-Benefit Analysis; Gold; Humans; Imaging, Three-Dimensional; Male; Prospective Studies; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Setup Errors; Radiotherapy, Image-Guided | 2012 |
Independent verification of ultrasound based image-guided radiation treatment, using electronic portal imaging and implanted gold markers.
Topics: Adenocarcinoma; Algorithms; Contrast Media; Equipment Failure Analysis; Gold; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Movement; Prostatic Neoplasms; Radiography; Radiotherapy, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2003 |
Effects of urethrography on prostate position: considerations for radiotherapy treatment planning of prostate carcinoma.
Topics: Adenocarcinoma; Computer Simulation; Gold; Humans; Male; Neoplasm Staging; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Urethra; Urography | 2000 |
337 other study(ies) available for gold and Prostatic Neoplasms
| Article | Year |
|---|---|
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment.
Topics: Cell Line, Tumor; Cell Survival; DNA Breaks, Double-Stranded; Endocytosis; Gold; Humans; Male; Metal Nanoparticles; Models, Biological; Nanostructures; Prostatic Neoplasms; Radiation, Ionizing; ral GTP-Binding Proteins | 2021 |
Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Epithelial Cell Adhesion Molecule; Gold; HEK293 Cells; Humans; Magnetic Iron Oxide Nanoparticles; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; SELEX Aptamer Technique; Xenograft Model Antitumor Assays | 2021 |
Bombesin Peptide Conjugated Water-Soluble Chitosan Gallate-A New Nanopharmaceutical Architecture for the Rapid One-Pot Synthesis of Prostate Tumor Targeted Gold Nanoparticles.
Topics: Bombesin; Cell Line, Tumor; Chitosan; Gold; Humans; Male; Metal Nanoparticles; Peptides; Prostatic Neoplasms; Water | 2021 |
Construction of a sensitive and selective plasmonic biosensor for prostate specific antigen by combining magnetic molecularly-imprinted polymer and surface-enhanced Raman spectroscopy.
Topics: Biomarkers, Tumor; Biosensing Techniques; Gold; Humans; Magnetic Phenomena; Male; Metal Nanoparticles; Middle Aged; Molecular Imprinting; Molecularly Imprinted Polymers; Polymers; Prostate-Specific Antigen; Prostatic Neoplasms; Spectrum Analysis, Raman | 2022 |
Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: An in vitro study.
Topics: Cell Line, Tumor; Gold; Humans; Infrared Rays; Male; Metal Nanoparticles; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms | 2021 |
Simultaneous detection of dual biomarkers using hierarchical MoS
Topics: Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Molybdenum; Overtreatment; Prostate-Specific Antigen; Prostatic Neoplasms; Silicon Dioxide | 2022 |
Ablation of Red Stable Transfected Claudin Expressing Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cell Lines by C-CPE Gold-Nanoparticle-Mediated Laser Intervention.
Topics: Adenocarcinoma; Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Clostridium perfringens; Dog Diseases; Dogs; Enterotoxins; Gold; Laser Therapy; Male; Metal Nanoparticles; Prostatic Neoplasms | 2021 |
The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis.
Topics: Cell Count; Cell Survival; Culture Media; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Secretome; Single-Cell Analysis; Tumor Cells, Cultured | 2021 |
Detection of prostate specific antigen in whole blood by microfluidic chip integrated with dielectrophoretic separation and electrochemical sensing.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Microfluidics; Prostate-Specific Antigen; Prostatic Neoplasms | 2022 |
Prostate-Specific Membrane Antigen-1-Mediated Au@SiO₂@Au Core-Shell Nanoparticles: Targeting Prostate Cancer to Enhance Photothermal Therapy and Fluorescence Imaging.
Topics: Animals; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Mice; Optical Imaging; Phototherapy; Photothermal Therapy; Prostate; Prostatic Neoplasms; Silicon Dioxide | 2022 |
Three-dimensional hierarchical plasmonic nano-architecture based label-free surface-enhanced Raman spectroscopy detection of urinary exosomal miRNA for clinical diagnosis of prostate cancer.
Topics: Biosensing Techniques; Gold; Humans; Male; Metal Nanoparticles; MicroRNAs; Prostatic Neoplasms; Spectrum Analysis, Raman | 2022 |
Targeted Chemoradiotherapy of Prostate Cancer Using Gold Nanoclusters with Protease Activatable Monomethyl Auristatin E.
Topics: Cell Line, Tumor; Chemoradiotherapy; Gold; Humans; Male; Oligopeptides; Peptide Hydrolases; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2022 |
A dual-mode immunosensing strategy for prostate specific antigen detection: Integration of resonance Raman scattering and photoluminescence properties of ZnS:Mn
Topics: Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Spectrum Analysis, Raman; Sulfides; Zinc Compounds | 2022 |
Sensitive recognition of prostate-specific antigen using biotinylated antibody encapsulated on D-penicillamine decorated wrinkled silicate nanoparticles (WSN): An innovative sandwich-type biosensor toward diagnosis of prostate cancer.
Topics: Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Penicillamine; Prostate-Specific Antigen; Prostatic Neoplasms; Silicates | 2022 |
Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles.
Topics: Animals; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Prostate; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2022 |
DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis.
Topics: Animals; Biomarkers, Tumor; Biopsy; DNA; Gold; Humans; Liquid Biopsy; Male; Metal Nanoparticles; Mice; MicroRNAs; Prostate-Specific Antigen; Prostatic Neoplasms; Technology | 2022 |
Au-Se bonded nanoprobe for prostate specific antigen detection in serum.
Topics: Biosensing Techniques; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium | 2022 |
Detection of Prostate Cancer Biomarker PCA3 by Using Aptasensors.
Topics: Antigens, Neoplasm; Aptamers, Nucleotide; Biomarkers, Tumor; DNA; Gold; Humans; Male; Methylene Blue; Prostate; Prostatic Neoplasms; RNA, Messenger | 2022 |
A novel biorecognition receptor Citropin-A modified impedimetric biosensor for detection of LNCaP prostate cancer cells.
Topics: Biosensing Techniques; Dielectric Spectroscopy; Electrodes; Gold; Humans; Limit of Detection; Lymph Nodes; Male; Prostatic Neoplasms | 2022 |
AuNCs-LHRHa nano-system for FL/CT dual-mode imaging and photothermal therapy of targeted prostate cancer.
Topics: Gold; Gonadotropin-Releasing Hormone; Humans; Male; Photothermal Therapy; Prostatic Neoplasms; Tomography, X-Ray Computed | 2022 |
Studies on the Effect of Graphene Oxide Deposited on Gold and Nickel Microsieves on Prostate Cancer Cells DU 145.
Topics: Gold; Graphite; Humans; Male; Nickel; Oxides; Prostate; Prostatic Neoplasms | 2022 |
Aptamer-based chemiluminescent optical fiber immunosensor with enhanced signal amplification for ultrasensitive detection of tumor biomarkers.
Topics: Biomarkers, Tumor; Biosensing Techniques; Gold; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Optical Fibers; Prostatic Neoplasms | 2022 |
Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles.
Topics: DNA; Gold; Humans; Male; Metal Nanoparticles; Prostate; Prostatic Neoplasms | 2022 |
Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Gold; Heterografts; Humans; Male; Metal Nanoparticles; Mice; Nanoparticles; Prostatic Neoplasms; Taxoids | 2022 |
Ultrasensitive visual detection of miRNA-143 using a CRISPR/Cas12a-based platform coupled with hyperbranched rolling circle amplification.
Topics: CRISPR-Cas Systems; Gold; Humans; Male; Metal Nanoparticles; MicroRNAs; Nucleic Acid Amplification Techniques; Prostatic Neoplasms | 2023 |
Targeted non AR mediated smart delivery of abiraterone to the prostate cancer.
Topics: Androstenes; Apoptosis; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Survivin | 2022 |
Cyclodextrin-Functionalized Gold Nanorods Loaded with Meclofenamic Acid for Improving
Topics: Adenosine; Cell Line, Tumor; Cyclodextrins; Gold; Humans; Immunotherapy; Male; Meclofenamic Acid; Nanotubes; Phototherapy; Prostatic Neoplasms; RNA; Tumor Microenvironment | 2022 |
Immunoarray Measurements of Parathyroid Hormone-Related Peptides Combined with Other Biomarkers to Diagnose Aggressive Prostate Cancer.
Topics: Biomarkers, Tumor; Carbon; Glutathione; Gold; Humans; Hydrogen Peroxide; Insulin-Like Growth Factor I; Male; Metal Nanoparticles; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peroxidases; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Vascular Endothelial Growth Factor D | 2022 |
Detection of prostate cancer biomarkers via a SERS-based aptasensor.
Topics: Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Dimaprit; DNA, Complementary; Gold; Guanine; Humans; Limit of Detection; Male; Metal Nanoparticles; Methylene Blue; Polystyrenes; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Spectrum Analysis, Raman | 2022 |
PSMA1-mediated ultrasmall gold nanoparticles facilitate tumor targeting and MR/CT/NIRF multimodal detection of early-stage prostate cancer.
Topics: Animals; Gold; Humans; Magnetic Resonance Spectroscopy; Male; Metal Nanoparticles; Mice; Prostate; Prostatic Neoplasms; Tomography, X-Ray Computed | 2023 |
Degradable multifunctional gold-liposomes as an all-in-one theranostic platform for image-guided radiotherapy.
Topics: Gold; Humans; Liposomes; Male; Metal Nanoparticles; Precision Medicine; Prostatic Neoplasms; Radiotherapy, Image-Guided | 2022 |
Gold Nanoparticles-MWCNT Based Aptasensor for Early Diagnosis of Prostate Cancer.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Early Detection of Cancer; Electrochemical Techniques; Electrodes; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Nanotubes, Carbon; Prostate-Specific Antigen; Prostatic Neoplasms | 2022 |
A novel peptide-templated AgNPs nanoprobe for theranostics of prostate cancer.
Topics: Biosensing Techniques; Electrochemical Techniques; Exosomes; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Peptides; Precision Medicine; Prostatic Neoplasms; Silver | 2023 |
Image-Guided Nanodelivery of Pt(IV) Prodrugs to GRP-Receptor Positive Tumors.
Topics: Animals; Cisplatin; Gold; Humans; Male; Metal Nanoparticles; Mice; Polyethylene Glycols; Prodrugs; Prostatic Neoplasms; Receptors, Bombesin | 2023 |
Discrimination between protein glycoforms using lectin-functionalised gold nanoparticles as signal enhancers.
Topics: Antibodies; Glycosylation; Gold; Humans; Lectins; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2023 |
Effects of gold fiducial marker implantation on tumor control and toxicity in external beam radiotherapy of prostate cancer.
Topics: Fiducial Markers; Gold; Humans; Male; Prostatic Neoplasms; Radiotherapy, Image-Guided; Retrospective Studies | 2023 |
D2B-Functionalized Gold Nanoparticles: Promising Vehicles for Targeted Drug Delivery to Prostate Cancer.
Topics: Drug Delivery Systems; Excipients; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2023 |
Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer.
Topics: Folic Acid; Gold; Humans; Male; Metal Nanoparticles; Polyethylene Glycols; Polylysine; Prostatic Neoplasms; RNA, Small Interfering | 2023 |
Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines.
Topics: Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2023 |
Metabolic Disruption of Gold Nanospheres, Nanostars and Nanorods in Human Metastatic Prostate Cancer Cells.
Topics: Gold; Humans; Male; Metal Nanoparticles; Nanospheres; Nanotubes; Prostatic Neoplasms | 2023 |
Microfluidic Platform Integrated with Carbon Nanofibers-Decorated Gold Nanoporous Sensing Device for Serum PSA Quantification.
Topics: Biosensing Techniques; Carbon; Electrochemical Techniques; Gold; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Microfluidics; Nanofibers; Nanopores; Prostate-Specific Antigen; Prostatic Neoplasms | 2023 |
SERS-based biosensor for detection of f-PSA%: Implications for the diagnosis of prostate cancer.
Topics: Antibodies; Biosensing Techniques; Gold; Humans; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Spectrum Analysis, Raman | 2023 |
Evaluation of a photodynamic therapy agent using a canine prostate cancer model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dogs; Gold; Humans; Male; Metal Nanoparticles; Photochemotherapy; Prostate; Prostatic Neoplasms | 2023 |
The use of virtual reality hypnosis for prostate cancer patients during transperineal biopsy/gold seed implantation: A needs assessment study.
Topics: Biopsy; Gold; Humans; Hypnosis; Male; Needs Assessment; Pain; Pilot Projects; Prospective Studies; Prostate; Prostatic Neoplasms; Virtual Reality | 2023 |
Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients.
Topics: Fiducial Markers; Gold; Humans; Male; Neoplasms, Second Primary; Prostate; Prostatic Neoplasms; Radiotherapy, Image-Guided; Reproducibility of Results | 2023 |
Aptamer-based gold nanoparticle aggregates for ultrasensitive amplification-free detection of PSMA.
Topics: Aptamers, Nucleotide; Biomarkers, Tumor; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2023 |
Highly sensitive detection of prostate cancer specific PCA3 mimic DNA using SERS-based competitive lateral flow assay.
Topics: Antigens, Neoplasm; Biosensing Techniques; Cell Line, Tumor; DNA; DNA Probes; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Prostatic Neoplasms; Spectrum Analysis, Raman | 2019 |
Erythrocyte membrane-biointerfaced spherical nucleic acids: Robust performance for microRNA quantification.
Topics: Animals; Carbocyanines; DNA Probes; Erythrocyte Membrane; Fluorescent Dyes; Gold; Humans; Limit of Detection; Lung Neoplasms; Male; Mice, Inbred BALB C; MicroRNAs; Nanostructures; Nucleic Acid Hybridization; Prostatic Neoplasms; Spectrometry, Fluorescence | 2019 |
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Shape; Cell Survival; Endocytosis; Female; Gold; Humans; Inhibitory Concentration 50; Male; Metal Nanoparticles; Pancreatic Neoplasms; Particle Size; Polyphenols; Prostatic Neoplasms; Resveratrol; Spectrophotometry, Ultraviolet; Treatment Outcome | 2019 |
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.
Topics: Aged; Feasibility Studies; Follow-Up Studies; Gold; Humans; Image-Guided Biopsy; Infrared Rays; Laser Therapy; Magnetic Resonance Imaging, Interventional; Male; Metal Nanoparticles; Middle Aged; Multimodal Imaging; Nanoshells; Oligopeptides; Organs at Risk; Penile Erection; Pilot Projects; Prostate; Prostatic Neoplasms; Sexual Health; Ultrasonography, Interventional; Urogenital System | 2019 |
Combined Effects of Gold Nanoparticles and Ionizing Radiation on Human Prostate and Lung Cancer Cell Migration.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Endocytosis; Gold; Humans; Lung Neoplasms; Male; Metal Nanoparticles; Prostatic Neoplasms; Radiation, Ionizing | 2019 |
Ultrasensitive detection of prostate specific antigen using a personal glucose meter based on DNA-mediated immunoreaction.
Topics: Antibodies, Immobilized; Biosensing Techniques; DNA; Gold; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2019 |
Gold Nanoshells Ablate Prostate Tumors.
Topics: Ablation Techniques; Gold; Humans; Male; Nanoshells; Prostatic Neoplasms | 2019 |
A novel label-free colorimetric aptasensor for sensitive determination of PSA biomarker using gold nanoparticles and a cationic polymer in human serum.
Topics: Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Blood Chemical Analysis; Cations; Colorimetry; Early Detection of Cancer; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Polyethylenes; Polymers; Prostate-Specific Antigen; Prostatic Neoplasms; Quaternary Ammonium Compounds; Reproducibility of Results; Sensitivity and Specificity; Serum | 2020 |
Re: Gold Nanoshell-Localized Photothermal Ablation of Prostate Tumors in a Clinical Pilot Device Study.
Topics: Gold; Humans; Hyperthermia, Induced; Male; Nanoshells; Prostatic Neoplasms | 2020 |
Enhanced radiosensitivity of LNCaP prostate cancer cell line by gold-photoactive nanoparticles modified with folic acid.
Topics: Cell Line, Tumor; Cell Survival; Folic Acid; Gold; Humans; Male; Metal Nanoparticles; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Radiation Tolerance | 2020 |
Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
Topics: Anatomic Landmarks; Fiducial Markers; Gold; Humans; Libraries, Digital; Lymph Nodes; Lymphatic Irradiation; Male; Organ Motion; Organ Sparing Treatments; Organs at Risk; Prostate; Prostatic Neoplasms; Proton Therapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Rectum; Retrospective Studies; Seminal Vesicles; Tomography, X-Ray Computed; Uncertainty; Urinary Bladder | 2020 |
Ultra-effective near-infrared Photothermal therapy for the prostate cancer Nursing care through novel intended and surface tailored photo-responsive Ga-Au@MPS nanovesicles.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; DNA Damage; Gallium; Gold; Humans; Infrared Rays; Male; Nanocomposites; Nursing Care; Phototherapy; Porosity; Prostatic Neoplasms; Silicon Dioxide | 2020 |
A novel electroconductive interface based on Fe
Topics: Electrochemical Techniques; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Prostatic Neoplasms | 2020 |
Radio-thermo-sensitivity Induced by Gold Magnetic Nanoparticles in the Monolayer Culture of Human Prostate Carcinoma Cell Line DU145.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Gold; Humans; Hyperthermia, Induced; Magnetite Nanoparticles; Male; Phototherapy; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Surface Properties | 2020 |
Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
Topics: Artifacts; Cone-Beam Computed Tomography; Fiducial Markers; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Organs at Risk; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Signal-To-Noise Ratio | 2019 |
Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
Topics: Computer Simulation; Fiducial Markers; Gold; Humans; Iron; Magnetic Resonance Imaging; Male; Phantoms, Imaging; Platinum; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2020 |
Electrochemical nano-genosensor for highly sensitive detection of miR-21 biomarker based on SWCNT-grafted dendritic Au nanostructure for early detection of prostate cancer.
Topics: Adult; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Male; MicroRNAs; Nanostructures; Nanotubes, Carbon; Prostatic Neoplasms | 2020 |
Determination of prostate cancer marker Zn
Topics: Cations, Divalent; Formazans; Gold; Humans; Limit of Detection; Male; Nanostructures; Prostate; Prostatic Neoplasms; Spectrum Analysis, Raman; Zinc | 2020 |
Bifunctional Au-templated RNA nanoparticles enable direct cell uptake detection and GRP75 knockdown in prostate cancer.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Gold; HSP70 Heat-Shock Proteins; Humans; Male; Mitochondrial Proteins; Molecular Structure; Nanoparticles; Particle Size; PC-3 Cells; Prostatic Neoplasms; RNA, Small Interfering; Surface Properties; Theranostic Nanomedicine | 2020 |
Papain Mediated Synthesized Gold Nanoparticles Encore the Potency of Bioconjugated Flutamide.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Nucleus; Drug Carriers; Drug Delivery Systems; Drug Stability; Endocytosis; Flutamide; Gold; Humans; Macrophages; Male; Metal Nanoparticles; Papain; Particle Size; Prostatic Neoplasms; Reactive Oxygen Species; Spectrophotometry, Ultraviolet | 2021 |
Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy.
Topics: Aged; Aged, 80 and over; Dose Fractionation, Radiation; Feasibility Studies; Fiducial Markers; Gold; Humans; Male; Middle Aged; Organ Motion; Patient Positioning; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Seminal Vesicles; Time Factors; Uncertainty | 2020 |
Study of the application of gold nanoparticles for early detection of prostate cancer.
Topics: Gold; Humans; Iran; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2020 |
In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3.
Topics: Animals; Antineoplastic Agents; Cell Growth Processes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Glucose Transporter Type 1; Gold; Humans; Male; Mice; Mice, Nude; Molecular Docking Simulation; Organometallic Compounds; PC-3 Cells; Prostatic Neoplasms; Random Allocation; Sulfhydryl Compounds; Thiocarbamates; Thioredoxin-Disulfide Reductase; Xenograft Model Antitumor Assays | 2020 |
The ligand exchange of citrates to thioabiraterone on gold nanoparticles for prostate cancer therapy.
Topics: Androstenes; Cell Line; Cell Survival; Citrates; Epithelial Cells; Gold; Humans; Ligands; Liver; Male; Metal Nanoparticles; Prostate; Prostatic Neoplasms; Sulfhydryl Compounds | 2020 |
A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer.
Topics: Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Male; Metal Nanoparticles; Particle Size; Prostate-Specific Antigen; Prostatic Neoplasms | 2020 |
Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer.
Topics: Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2020 |
Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Membrane; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Gold; Humans; Indocyanine Green; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Particle Size; PC-3 Cells; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Polymers; Prostatic Neoplasms; Reactive Oxygen Species; Surface Properties | 2020 |
Radiotherapy for prostate cancer: Effect of gold fiducial markers on diffusion-weighted magnetic resonance imaging.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fiducial Markers; Gold; Humans; Male; Prostatic Neoplasms; Radiotherapy, Image-Guided | 2021 |
SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells.
Topics: Epithelial Cells; Glioblastoma; Gold; Humans; Leukocytes, Mononuclear; Male; Mesenchymal Stem Cells; Nanostructures; Prostatic Neoplasms; Spectrum Analysis, Raman; Tumor Cells, Cultured | 2020 |
Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3.
Topics: Antigens, Neoplasm; Biomarkers; Biomarkers, Tumor; Gold; Humans; Machine Learning; Male; Metal Nanoparticles; Prostatic Neoplasms | 2021 |
Development and evaluation of a deep learning based artificial intelligence for automatic identification of gold fiducial markers in an MRI-only prostate radiotherapy workflow.
Topics: Deep Learning; Fiducial Markers; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Radiotherapy, Image-Guided; Workflow | 2020 |
Gold nanoparticles regulate the antitumor secretome and have potent cytotoxic effects against prostate cancer cells.
Topics: Cell Line, Tumor; Cytotoxins; Electrophoresis, Gel, Two-Dimensional; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Photoelectron Spectroscopy; Prostatic Neoplasms; Secretome; Spectrophotometry, Atomic | 2021 |
The Role of Gold Nanorods in the Response of Prostate Cancer and Normal Prostate Cells to Ionizing Radiation-In Vitro Model.
Topics: Cell Cycle; Cell Line; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanotubes; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radiation, Ionizing; Reactive Oxygen Species; Time Factors | 2020 |
The electrochemical immunosensor for detection of prostatic specific antigen using quince seed mucilage-GNPs-SNPs as a green composite.
Topics: Biomarkers, Tumor; Biosensing Techniques; Calendula; Dielectric Spectroscopy; Gold; Green Chemistry Technology; Humans; Kallikreins; Male; Metal Nanoparticles; Nanocomposites; Plant Extracts; Plant Mucilage; Prostate-Specific Antigen; Prostatic Neoplasms; Rosaceae; Seeds; Silver | 2021 |
An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
Topics: Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Gold; Humans; Male; Metal Nanoparticles; Particle Size; Polyethylene Glycols; Prostatic Neoplasms | 2021 |
GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism.
Topics: Gold; Humans; Male; Prostatic Neoplasms; Receptors, Bombesin; Silicon Dioxide; Thermodynamics | 2021 |
Colloidal Stability and Cytotoxicity of Polydopamine-Conjugated Gold Nanorods against Prostate Cancer Cell Lines.
Topics: Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Cell Proliferation; Gold; Humans; Indoles; Male; Nanoconjugates; Nanotubes; Polyethylene Glycols; Polymers; Prostatic Neoplasms; Surface Properties | 2021 |
Au-Ag assembled on silica nanoprobes for visual semiquantitative detection of prostate-specific antigen.
Topics: Biosensing Techniques; Colorimetry; Gold; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Silicon Dioxide; Silver | 2021 |
A target-triggered and self-calibration aptasensor based on SERS for precise detection of a prostate cancer biomarker in human blood.
Topics: Biomarkers, Tumor; Biosensing Techniques; Calibration; Early Detection of Cancer; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Spectrum Analysis, Raman | 2021 |
Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines.
Topics: Cell Line; Genistein; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2021 |
Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
Topics: Animals; Antigens, Surface; Glutamate Carboxypeptidase II; Gold; Humans; Male; Metal Nanoparticles; Mice; Optical Imaging; Prostatic Neoplasms; Tomography, X-Ray Computed | 2021 |
Lateral flow immunoassay based on gold magnetic nanoparticles for the protein quantitative detection: Prostate-specific antigen.
Topics: Acrylic Resins; Biomarkers, Tumor; Gold; Humans; Immunoassay; Limit of Detection; Magnetics; Magnetite Nanoparticles; Male; Point-of-Care Testing; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity | 2021 |
Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro.
Topics: DNA; Drug Carriers; Gene Transfer Techniques; Genetic Therapy; Gold; Humans; Lactoferrin; Male; Plasmids; Polyethylene Glycols; Polyethyleneimine; Prostatic Neoplasms; Transfection | 2021 |
A SERS-LFA biosensor combined with aptamer recognition for simultaneous detection of thrombin and PDGF-BB in prostate cancer plasma.
Topics: Aged; Antibodies, Monoclonal; Aptamers, Nucleotide; Becaplermin; Biosensing Techniques; Blood Chemical Analysis; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Middle Aged; Oxazines; Prostatic Neoplasms; Sensitivity and Specificity; Silver; Spectrum Analysis, Raman; Thrombin | 2021 |
Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy.
Topics: Animals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gold; Green Chemistry Technology; Heterografts; Humans; Immunologic Factors; Interleukin-12; Macrophages; Male; Metal Nanoparticles; Mice; Prostatic Neoplasms; Signal Transduction; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Xanthones | 2021 |
A highly sensitive capillary electrophoresis immunoassay strategy based on dual-labeled gold nanoparticles enhancing chemiluminescence for the detection of prostate-specific antigen.
Topics: Adult; Aged; Biomarkers, Tumor; Electrophoresis, Capillary; Gold; Humans; Immunoassay; Limit of Detection; Linear Models; Luminescent Measurements; Male; Metal Nanoparticles; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results | 2017 |
Functional fusion proteins and prevention of electrode fouling for a sensitive electrochemical immunosensor.
Topics: Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Male; Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins | 2017 |
Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT.
Topics: Aged; Cone-Beam Computed Tomography; Dose Fractionation, Radiation; Fiducial Markers; Gold; Humans; Male; Middle Aged; Motion; Organs at Risk; Patient Positioning; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Setup Errors; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Rectum; Software | 2017 |
Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor.
Topics: Biomarkers, Tumor; Biosensing Techniques; Electrodes; Gold; Graphite; Humans; Immunoassay; Male; Metal Nanoparticles; Oxides; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Surface Properties; Tumor Cells, Cultured | 2017 |
Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
Topics: Aged; Aged, 80 and over; Automation; Fiducial Markers; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2017 |
An ultrasensitive sandwich-type electrochemical immunosensor based on the signal amplification strategy of echinoidea-shaped Au@Ag-Cu
Topics: Antibodies, Immobilized; Biosensing Techniques; Early Detection of Cancer; Gold; Graphite; Humans; Immunoassay; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Quantum Dots | 2018 |
A new label-free electrochemical immunosensor based on dendritic core-shell AuPd@Au nanocrystals for highly sensitive detection of prostate specific antigen.
Topics: Antibodies, Immobilized; Biosensing Techniques; Dendritic Cells; Early Detection of Cancer; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
Topics: Automation; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Patient Positioning; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2017 |
Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.
Topics: Animals; Anthraquinones; Apoptosis; Cell Line, Tumor; Disease Progression; Enzyme Activation; Female; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Random Allocation; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2017 |
A signal-on built in-marker electrochemical aptasensor for human prostate-specific antigen based on a hairbrush-like gold nanostructure.
Topics: Blood Chemical Analysis; Diagnostic Tests, Routine; Gold; Humans; Male; Nanostructures; Prostate-Specific Antigen; Prostatic Neoplasms | 2017 |
Electrochemical aptamer-based biosensor developed to monitor PSA and VEGF released by prostate cancer cells.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Vascular Endothelial Growth Factor A | 2017 |
Comparison of MRI visualization between linearly placed iron-containing and non-iron-containing fiducial markers for prostate radiotherapy.
Topics: Fiducial Markers; Gold; Humans; Iron; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2018 |
Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.
Topics: Animals; Antineoplastic Agents; Docetaxel; Drug Delivery Systems; Gold; Humans; Hyperthermia, Induced; Liposomes; Male; Mice, Nude; Nanomedicine; Nanotubes; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Receptors, LDL; Taxoids; Xenograft Model Antitumor Assays | 2017 |
Detection of early stage prostate cancer by using a simple carbon nanotube@paper biosensor.
Topics: Biomarkers, Tumor; Biosensing Techniques; Early Detection of Cancer; Enzyme-Linked Immunosorbent Assay; Gold; Humans; Male; Metal Nanoparticles; Nanotubes, Carbon; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
Superwettable microchips with improved spot homogeneity toward sensitive biosensing.
Topics: Biosensing Techniques; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Oligonucleotide Array Sequence Analysis; Prostate-Specific Antigen; Prostatic Neoplasms; Silicon Dioxide | 2018 |
Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
Topics: Aged; Aged, 80 and over; Fiducial Markers; Gold; Humans; Image Processing, Computer-Assisted; Iron; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2018 |
Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells.
Topics: Antibodies; Cell Line, Tumor; Gold; Humans; Magnetite Nanoparticles; Male; Phototherapy; Prostatic Neoplasms; Spectrum Analysis, Raman | 2018 |
Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles.
Topics: Animals; Brachytherapy; Erbium; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Nude; PC-3 Cells; Prostate; Prostatic Neoplasms; Radiation-Sensitizing Agents; X-Rays | 2017 |
A comparative Study of Aptasensor Vs Immunosensor for Label-Free PSA Cancer Detection on GQDs-AuNRs Modified Screen-Printed Electrodes.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Calibration; Dielectric Spectroscopy; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Male; Nanotubes; Printing; Prostate-Specific Antigen; Prostatic Neoplasms; Quantum Dots; Reproducibility of Results; Staining and Labeling; Surface Properties | 2018 |
Selected landscape phage probe as selective recognition interface for sensitive total prostate-specific antigen immunosensor.
Topics: Bacteriophages; Biosensing Techniques; Enzyme-Linked Immunosorbent Assay; Gold; Humans; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
Intratumoral Injection of Low-Energy Photon-Emitting Gold Nanoparticles: A Microdosimetric Monte Carlo-Based Model.
Topics: Animals; Brachytherapy; Gold; Humans; Injections, Intralesional; Male; Metal Nanoparticles; Mice; Monte Carlo Method; Palladium; PC-3 Cells; Photons; Prostatic Neoplasms; Radioisotopes; Radiometry | 2018 |
Development of an electrochemical immunosensor based on gold nanoparticles incorporated chitosan biopolymer nanocomposite film for the detection of prostate cancer using PSA as biomarker.
Topics: Biosensing Techniques; Chitosan; Electrochemical Techniques; Equipment Design; Gold; Humans; Male; Metal Nanoparticles; Nanocomposites; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Imaging.
Topics: Animals; Antigens, Surface; Glutamate Carboxypeptidase II; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Fluorescence; Optical Imaging; PC-3 Cells; Peptides; Positron-Emission Tomography; Prostatic Neoplasms; Rats; Receptors, Bombesin | 2018 |
Improved sandwich-format electrochemical immunosensor based on "smart" SiO
Topics: Biosensing Techniques; Electrochemical Techniques; Gold; Graphite; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Indoles; Kallikreins; Limit of Detection; Male; Metal Nanoparticles; Polymers; Prostate-Specific Antigen; Prostatic Neoplasms; Silicon Dioxide | 2018 |
Fabrication of an amperometric sarcosine biosensor based on sarcosine oxidase/chitosan/CuNPs/c-MWCNT/Au electrode for detection of prostate cancer.
Topics: Biosensing Techniques; Chitosan; Copper; Dielectric Spectroscopy; Electrodes; Female; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Scanning; Nanotubes, Carbon; Prostatic Neoplasms; Sarcosine; Sarcosine Oxidase | 2018 |
Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Nude; Neoplasms, Experimental; Peptides; Photochemotherapy; Prostate-Specific Antigen; Prostatic Neoplasms; Structure-Activity Relationship; Theranostic Nanomedicine; Tumor Cells, Cultured | 2018 |
Quantitative Detection of Prostatic-Specific Antigens by Using Scanning Electron Microscopy for the Analysis of Protein Chips.
Topics: Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Microscopy, Electron, Scanning; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Array Analysis | 2017 |
Gold nanoparticle-based colorimetric method for the detection of prostate-specific antigen.
Topics: Ascorbic Acid; Biosensing Techniques; Colorimetry; Copper; Gold; Humans; Immobilized Proteins; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Topics: Aged; Aged, 80 and over; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Patient Positioning; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Reproducibility of Results; Tomography, X-Ray Computed | 2018 |
Intracellular Biodegradation of Ag Nanoparticles, Storage in Ferritin, and Protection by a Au Shell for Enhanced Photothermal Therapy.
Topics: Animals; Cell Line; Ferritins; Gold; Humans; Hyperthermia, Induced; Male; Metal Nanoparticles; Mice, Nude; PC-3 Cells; Phototherapy; Prostatic Neoplasms; Silver | 2018 |
Sandwich pair nanobodies, a potential tool for electrochemical immunosensing serum prostate-specific antigen with preferable specificity.
Topics: Animals; Biosensing Techniques; Camelids, New World; Electrochemical Techniques; Freund's Adjuvant; Gold; Graphite; Humans; Immunoassay; Kallikreins; Limit of Detection; Male; Metal Nanoparticles; Peptide Library; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Single-Domain Antibodies | 2018 |
Intraoperative Detection and Eradication of Residual Microtumors with Gap-Enhanced Raman Tags.
Topics: Animals; Cell Line, Tumor; Gold; Humans; Male; Mice; Mice, SCID; Neoplasms, Experimental; Prostatic Neoplasms; Spectrum Analysis, Raman; Tissue Distribution | 2018 |
Enzyme-triggered self-assembly of gold nanoparticles for enhanced retention effects and photothermal therapy of prostate cancer.
Topics: Alkaline Phosphatase; Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Line, Tumor; Gold; Humans; Light; Male; Metal Nanoparticles; Mice, Inbred BALB C; Oligopeptides; Particle Size; Phototherapy; Prostatic Neoplasms; Temperature | 2018 |
Construction and application of amperometric sarcosine biosensor based on SOxNPs/AuE for determination of prostate cancer.
Topics: Bacillus; Biosensing Techniques; Electrodes; Enzymes, Immobilized; Gold; Humans; Limit of Detection; Male; Nanoparticles; Prostatic Neoplasms; Sarcosine; Sarcosine Oxidase | 2018 |
Combining SERS analysis of serum with PSA levels for improving the detection of prostate cancer.
Topics: Aged; Discriminant Analysis; Early Detection of Cancer; Gold; Humans; Male; Middle Aged; Neoplasm Grading; Principal Component Analysis; Prostate-Specific Antigen; Prostatic Neoplasms; Spectrum Analysis, Raman | 2018 |
Functionalized Gold Nanoparticles as Biosensors for Monitoring Cellular Uptake and Localization in Normal and Tumor Prostatic Cells.
Topics: Biosensing Techniques; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanostructures; PC-3 Cells; Prostatic Neoplasms; Spectrum Analysis, Raman | 2018 |
Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Fiducial Markers; Follow-Up Studies; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2018 |
Colorimetric detection of PCA3 in urine for prostate cancer diagnosis using thiol-labeled PCR primer and unmodified gold nanoparticles.
Topics: Adult; Aged; Antigens, Neoplasm; Cells, Cultured; Colorimetry; Gold; Humans; Male; Metal Nanoparticles; Middle Aged; Particle Size; Polymerase Chain Reaction; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfhydryl Compounds; Surface Properties | 2019 |
An Ultra-Rapid Biosensory Point-of-Care (POC) Assay for Prostate-Specific Antigen (PSA) Detection in Human Serum.
Topics: Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Point-of-Care Systems; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
A colorimetric paper sensor for citrate as biomarker for early stage detection of prostate cancer based on peroxidase-like activity of cysteine-capped gold nanoclusters.
Topics: Biomarkers, Tumor; Citric Acid; Colorimetry; Cysteine; Gold; Humans; Lab-On-A-Chip Devices; Limit of Detection; Male; Microscopy, Electron, Transmission; Nanostructures; Paper; Peroxidase; Prostatic Neoplasms; Spectrometry, Fluorescence | 2019 |
Focusing aptamer selection on the glycan structure of prostate-specific antigen: Toward more specific detection of prostate cancer.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Gold; Humans; Limit of Detection; Male; Polysaccharides; Prostate-Specific Antigen; Prostatic Neoplasms | 2019 |
Intelligent Photosensitive Mesenchymal Stem Cells and Cell-Derived Microvesicles for Photothermal Therapy of Prostate Cancer.
Topics: Animals; Cell Line, Tumor; Cell-Derived Microparticles; Gold; Humans; Injections, Intravenous; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Metal Nanoparticles; Mice; Particle Size; Phototherapy; Prostatic Neoplasms; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
Topics: Aged; Discriminant Analysis; Gold; Humans; Kaplan-Meier Estimate; Male; Metal Nanoparticles; Multivariate Analysis; Neoplasm Recurrence, Local; Principal Component Analysis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Risk Assessment; ROC Curve; Spectrum Analysis, Raman | 2019 |
An electrochemical sarcosine sensor based on biomimetic recognition.
Topics: Biomarkers, Tumor; Biomimetic Materials; Biosensing Techniques; Chitosan; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Limit of Detection; Male; Metal Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Pyrroles; Riboflavin; Sarcosine; Sarcosine Oxidase; Surface Properties | 2019 |
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzamides; Cell Line, Tumor; Combined Modality Therapy; Gene Knockdown Techniques; Gene Transfer Techniques; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Paclitaxel; Polyethylene Glycols; Polyethyleneimine; Prostatic Neoplasms; RNA, Small Interfering; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core.
Topics: Antibodies, Immobilized; Biosensing Techniques; Dielectric Spectroscopy; Gold; Humans; Male; Nanoshells; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 2019 |
Determination of prostate cancer biomarker acid phosphatase at a copper phthalocyanine-modified screen printed gold transducer.
Topics: Acid Phosphatase; Biomarkers, Tumor; Electrochemistry; Electrodes; Gold; Humans; Hydrogen-Ion Concentration; Indoles; Limit of Detection; Male; Organometallic Compounds; Perchlorates; Printing; Prostatic Neoplasms; Surface Properties; Time Factors; Transducers | 2019 |
Silica-Coated Gold Nanorods with High Photothermal Efficiency and Biocompatibility as a Contrast Agent for
Topics: Animals; Cetrimonium Compounds; Gold; Male; Nanotubes; Prostatic Neoplasms; Silicon Dioxide; Terahertz Imaging | 2019 |
Differentiating platinum coated brachytherapy seeds and gold fiducial markers with varying off-resonant frequency offsets.
Topics: Agar; Brachytherapy; Color; Computer Simulation; Contrast Media; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Models, Theoretical; Phantoms, Imaging; Platinum; Prostatic Neoplasms; Prostheses and Implants; Reproducibility of Results; Tomography, X-Ray Computed | 2019 |
NF-κB inhibition promotes apoptosis in androgen-independent prostate cancer cells by the photothermal effect via the IκBα/AR signaling pathway.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gold; Hot Temperature; Humans; Indoles; Male; Metal Nanoparticles; Mitochondria; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Oxidative Stress; Phototherapy; Polymers; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Silver; Sulfones | 2019 |
An immunosensing device based on inhibition of mediator's faradaic process for early diagnosis of prostate cancer using bifunctional nanoplatform reinforced by carbon nanotube.
Topics: Biomarkers, Tumor; Biosensing Techniques; Early Detection of Cancer; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Nanotubes, Carbon; Oxides; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results | 2019 |
Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Topics: Cell Line, Tumor; Cell Survival; Gene Silencing; Gene Transfer Techniques; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; RNA, Small Interfering | 2019 |
Gold-caged copolymer nanoparticles as multimodal synergistic photodynamic/photothermal/chemotherapy platform against lethality androgen-resistant prostate cancer.
Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; Calcium Channels; Cell Cycle Checkpoints; Cell Line, Tumor; Endocytosis; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Inhibitory Concentration 50; Male; Metal Nanoparticles; Mice; Mice, Nude; Paclitaxel; Photochemotherapy; Phototherapy; Poloxamer; Polyethyleneimine; Polymers; Prostatic Neoplasms; Reactive Oxygen Species; TRPV Cation Channels; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Topics: alpha-Fetoproteins; Animals; Antibodies; Biomarkers, Tumor; Biosensing Techniques; Carcinoembryonic Antigen; Collodion; Coloring Agents; Goats; Gold; Humans; Immunoassay; Kallikreins; Limit of Detection; Male; Metal Nanoparticles; Oxazines; Porosity; Prostate-Specific Antigen; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds | 2019 |
Targeted Gold Nanocluster-Enhanced Radiotherapy of Prostate Cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Gold; Humans; Imaging, Three-Dimensional; Liver; Male; Metal Nanoparticles; Mice; Particle Size; Prostatic Neoplasms; Tomography, X-Ray Computed | 2019 |
Visualization of gold fiducial markers in the prostate using phase-cycled bSSFP imaging for MRI-only radiotherapy.
Topics: Artifacts; Fiducial Markers; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2019 |
A light-driven anti-cancer dual-therapeutic cassette enhances solid tumour regression.
Topics: Animals; Antibiotics, Antineoplastic; Benzeneacetamides; Cell Line; Cell Survival; DNA; Doxorubicin; Drug Design; Gold; Humans; Hyperthermia, Induced; Light; Male; Metal Nanoparticles; Mice; Mice, Nude; Nanoparticles; Piperidones; Prostatic Neoplasms; RNA; Transplantation, Heterologous | 2013 |
Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Gold; Humans; Hyperthermia, Induced; Male; Metal Nanoparticles; Mice; Mice, Nude; Nanoconjugates; Prostatic Neoplasms; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2013 |
Cancer incidence and mortality among underground and surface goldminers in Western Australia.
Topics: Gold; Humans; Incidence; Male; Mining; Neoplasms; Occupational Diseases; Prostatic Neoplasms; Risk; Western Australia | 2013 |
Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy. Technique and complications rate.
Topics: Aged; Anticoagulants; Biomarkers, Tumor; Combined Modality Therapy; Feasibility Studies; Fiducial Markers; Gastrointestinal Hemorrhage; Gold; Humans; Male; Middle Aged; Pain Measurement; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Rectal Diseases; Salvage Therapy; Ultrasonography, Interventional; Warfarin | 2013 |
Does hormone therapy modify the position of the gold markers in the prostate during irradiation? A daily evaluation with kV-images.
Topics: Androgen Antagonists; Fiducial Markers; Gold; Humans; Male; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2013 |
The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model.
Topics: Animals; Cell Line, Tumor; Cell Survival; Choline; Gold; Humans; Male; Metal Nanoparticles; Mice; Photoelectron Spectroscopy; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared | 2013 |
Aptamer-conjugated nanorods for targeted photothermal therapy of prostate cancer stem cells.
Topics: Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Gold; Humans; Infrared Rays; Male; Nanotubes; Neoplastic Stem Cells; Phototherapy; Prostatic Neoplasms | 2013 |
Anti-PSMA antibody-coupled gold nanorods detection by optical and electron microscopies.
Topics: Antibodies; Antigens, Surface; Glutamate Carboxypeptidase II; Gold; Humans; Male; Microscopy; Nanotubes; Prostatic Neoplasms | 2013 |
Photoluminescence and X-ray excited luminescence from glutathione-stabilized gold nanoparticles.
Topics: Cell Line, Tumor; Glutathione; Gold; Humans; Luminescent Measurements; Male; Metal Nanoparticles; Microscopy, Fluorescence; Particle Size; Prostatic Neoplasms; Sensitivity and Specificity; X-Rays | 2013 |
Competitive-type displacement reaction for direct potentiometric detection of low-abundance protein.
Topics: Antigen-Antibody Reactions; Biosensing Techniques; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanospheres; Potentiometry; Prostate-Specific Antigen; Prostatic Neoplasms; Surface Plasmon Resonance | 2014 |
Gold seed fiducials in analysis of linear and rotational displacement of the prostate bed.
Topics: Aged; Cone-Beam Computed Tomography; Fiducial Markers; Gold; Humans; Male; Middle Aged; Movement; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted | 2014 |
Gold nanocage assemblies for selective second harmonic generation imaging of cancer cell.
Topics: Cell Line, Tumor; Gold; Humans; Male; Microscopy, Fluorescence; Nanostructures; Prostate; Prostatic Neoplasms | 2014 |
A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
Topics: bcl-2-Associated X Protein; Cell Proliferation; Cell Survival; Chitosan; Citraconic Anhydrides; Gold; Green Fluorescent Proteins; HeLa Cells; Humans; Male; Metal Nanoparticles; Microscopy, Fluorescence; Plasmids; Polyamines; Polyethyleneimine; Prostatic Neoplasms; Transfection; Tumor Suppressor Protein p53 | 2014 |
Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions.
Topics: Breast Neoplasms; Cell Growth Processes; Cell Hypoxia; Cell Line, Tumor; Female; Gold; Humans; Lung; Male; Metal Nanoparticles; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2014 |
Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors.
Topics: Acrylamides; Animals; Cell Line, Tumor; Female; Gold; Heterocyclic Compounds, 1-Ring; Humans; Hyperthermia, Induced; Male; Mice; Nanotubes; Prostatic Neoplasms; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2014 |
Using fiducial markers in the prostate bed in postprostatectomy external beam radiation therapy improves accuracy over surgical clips.
Topics: Fiducial Markers; Foreign-Body Migration; Gold; Humans; Male; Neoplasm Grading; Neoplasm Staging; Observer Variation; Organs at Risk; Prostate; Prostatectomy; Prostatic Neoplasms; Radioisotope Teletherapy; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Retrospective Studies; Salvage Therapy; Surgical Instruments; Tomography, X-Ray Computed | 2014 |
Modular plasmonic nanocarriers for efficient and targeted delivery of cancer-therapeutic siRNA.
Topics: Amino Acid Sequence; Cell Line; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Endosomes; Gene Transfer Techniques; Gold; Humans; Lasers; Male; Nanocapsules; Neuropilin-1; Peptides; Prostate; Prostatic Neoplasms; RNA, Small Interfering | 2014 |
Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Drug Carriers; Drug Resistance, Neoplasm; Glutathione; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Neuropilin-1; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Peptides; Platinum; Prostatic Neoplasms; Protein Binding; Surface Properties; Ultraviolet Rays | 2014 |
Enhancing proteasome-lnhibitor effect by functionalized gold nanoparticles.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Proteasome Inhibitors; Pyrazines; Treatment Outcome | 2014 |
Single-center experience in prostate fiducial marker placement: technique and midterm follow-up.
Topics: Aged; Equipment Design; Fiducial Markers; Florida; Gold; Humans; Male; Middle Aged; Predictive Value of Tests; Prostatic Neoplasms; Radiotherapy, Image-Guided; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2014 |
The simultaneous detection of free and total prostate antigen in serum samples with high sensitivity and specificity by using the dual-channel surface plasmon resonance.
Topics: Binding, Competitive; Diagnosis, Differential; Early Diagnosis; Gold; Humans; Kallikreins; Male; Metal Nanoparticles; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Surface Plasmon Resonance | 2014 |
Development of a computational simulation tool to design a protocol for treating prostate tumours using transurethral laser photothermal therapy.
Topics: Computer Simulation; Finite Element Analysis; Gold; Humans; Hyperthermia, Induced; Laser Therapy; Male; Models, Theoretical; Monte Carlo Method; Nanotubes; Prostatic Neoplasms; Urethra | 2014 |
Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.
Topics: Alloys; Animals; Cell Line, Tumor; Copper Radioisotopes; Gold; Heterografts; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Prostatic Neoplasms; Tissue Distribution | 2014 |
Flexible gold electrode array for multiplexed immunoelectrochemical measurement of three protein biomarkers for prostate cancer.
Topics: Antibodies, Immobilized; Antigens, Surface; Biomarkers; Dimethylpolysiloxanes; Electrochemical Techniques; Electrodes; Glutamate Carboxypeptidase II; Gold; Humans; Hydrogen Peroxide; Immunoassay; Interleukin-6; Magnetics; Male; Microchip Analytical Procedures; Nanotubes; Peroxidases; Prostate-Specific Antigen; Prostatic Neoplasms | 2014 |
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer.
Topics: Animals; Brachytherapy; Dogs; Gold; Gum Arabic; Male; Metal Nanoparticles; Prostatic Neoplasms; Tomography, X-Ray Computed | 2014 |
Immunoreaction-triggered DNA assembly for one-step sensitive ratiometric electrochemical biosensing of protein biomarker.
Topics: Antibodies; Base Sequence; Biosensing Techniques; DNA; Electrochemical Techniques; Electrodes; Ferrous Compounds; Gold; Humans; Immunoassay; Limit of Detection; Male; Metallocenes; Methylene Blue; Nucleic Acid Hybridization; Prostate-Specific Antigen; Prostatic Neoplasms | 2015 |
Homogeneous immunoassays by using photon burst counting technique of single gold nanoparticles.
Topics: Antibodies, Monoclonal; Case-Control Studies; Gold; Humans; Immunoassay; Immunoconjugates; Limit of Detection; Male; Metal Nanoparticles; Photons; Prostate-Specific Antigen; Prostatic Neoplasms; Signal-To-Noise Ratio; Spectrum Analysis | 2015 |
Global transcriptomic analysis of model human cell lines exposed to surface-modified gold nanoparticles: the effect of surface chemistry.
Topics: Cell Line; Fibroblasts; Gene Expression Profiling; Gold; Humans; Liposomes; Male; Metal Nanoparticles; Oligonucleotide Array Sequence Analysis; Polyamines; Prostatic Neoplasms; RNA; Surface Properties | 2015 |
Automatic tracking of gold seed markers from CBCT image projections in lung and prostate radiotherapy.
Topics: Automation; Cone-Beam Computed Tomography; Dose Fractionation, Radiation; Fiducial Markers; Gold; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Movement; Prostatic Neoplasms | 2015 |
Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo.
Topics: Animals; Gold; Goserelin; Humans; Male; Metal Nanoparticles; Mice; Nanotubes; Prostate; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2015 |
Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate-risk and high-risk prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Disease-Free Survival; Fiducial Markers; Gold; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Factors; Treatment Outcome | 2015 |
Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Docetaxel; Drug Liberation; Drug Stability; Gold; Humans; Male; Mice; Nanospheres; Photochemotherapy; Prostatic Neoplasms; Radioligand Assay; Taxoids; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays | 2015 |
Gold nanoparticle-enabled blood test for early stage cancer detection and risk assessment.
Topics: Biomarkers, Tumor; Early Detection of Cancer; Gold; Hematologic Tests; Humans; Immunoglobulin G; Male; Metal Nanoparticles; Prostatic Neoplasms; Protein Corona | 2015 |
Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study.
Topics: Aged; Case-Control Studies; Discriminant Analysis; Gold; Humans; Hypoxanthine; Male; Middle Aged; Nanoparticles; Principal Component Analysis; Prostatic Neoplasms; Sensitivity and Specificity; Spectrum Analysis, Raman | 2015 |
Single-walled carbon nanotube based transparent immunosensor for detection of a prostate cancer biomarker osteopontin.
Topics: Biomarkers, Tumor; Biosensing Techniques; Electricity; Electrodes; Gold; Humans; Immunoassay; Limit of Detection; Male; Models, Molecular; Molecular Conformation; Nanotubes, Carbon; Osteopontin; Prostatic Neoplasms; Tin Compounds | 2015 |
Assessment of gold nanoparticle effect on prostate cancer LNCaP cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Shape; Dihydrotestosterone; Drug Screening Assays, Antitumor; Gold; Humans; Male; Metal Nanoparticles; Particle Size; Prostatic Neoplasms | 2015 |
Ultrasensitive electrochemical immunosensor for PSA biomarker detection in prostate cancer cells using gold nanoparticles/PAMAM dendrimer loaded with enzyme linked aptamer as integrated triple signal amplification strategy.
Topics: Aptamers, Nucleotide; Biomarkers, Tumor; Conductometry; Dendrimers; Enzyme-Linked Immunosorbent Assay; Equipment Design; Equipment Failure Analysis; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Systems Integration | 2015 |
Relating Intercellular Variability in Nanoparticle Uptake with Biological Consequence: A Quantitative X-ray Fluorescence Study for Radiosensitization of Cells.
Topics: Cells; Fluorescence; Gold; Humans; Light; Male; Metal Nanoparticles; Prostatic Neoplasms; X-Rays | 2015 |
Evaluation of a rapid quantitative determination method of PSA concentration with gold immunochromatographic strips.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, Affinity; Computer Systems; Equipment Design; Equipment Failure Analysis; Gold; Humans; Male; Middle Aged; Observer Variation; Prostate-Specific Antigen; Prostatic Neoplasms; Reagent Strips; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
Topics: Aged; Bone and Bones; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Rectum; Tomography, X-Ray Computed; Urinary Bladder | 2015 |
Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
Topics: Cone-Beam Computed Tomography; Fiducial Markers; Gold; Humans; Imaging, Three-Dimensional; Lymph Nodes; Male; Patient Positioning; Pelvis; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Seminal Vesicles | 2015 |
Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Topics: Brachytherapy; Choroid Neoplasms; Computer Simulation; Eye Neoplasms; Gold; Humans; Iodine Radioisotopes; Male; Melanoma; Metal Nanoparticles; Models, Biological; Models, Theoretical; Monte Carlo Method; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Uveal Neoplasms; Water | 2015 |
Cancer-Cells on Chip for Label-Free Detection of Secreted Molecules.
Topics: beta 2-Microglobulin; Biosensing Techniques; Cell Adhesion; Cell Line, Tumor; Dihydrotestosterone; Gold; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Tissue Array Analysis | 2016 |
Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, SCID; Nanostructures; Palladium; Particle Size; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Theranostic Nanomedicine; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2016 |
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Gold; Heterografts; Humans; Male; Metal Nanoparticles; Mice; Mice, Nude; Monte Carlo Method; Prostatic Neoplasms | 2016 |
Quantitative imaging of gold nanoparticle distribution in a tumor-bearing mouse using benchtop x-ray fluorescence computed tomography.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gold; Humans; Male; Metal Nanoparticles; Mice; Neoplasms, Experimental; Prostatic Neoplasms; Spectrometry, X-Ray Emission; Tomography, X-Ray Computed | 2016 |
Cancer Cell Internalization of Gold Nanostars Impacts Their Photothermal Efficiency In Vitro and In Vivo: Toward a Plasmonic Thermal Fingerprint in Tumoral Environment.
Topics: Cell Line, Tumor; Gold; Humans; Hypothermia, Induced; Male; Metal Nanoparticles; Phototherapy; Prostatic Neoplasms; Tumor Microenvironment | 2016 |
Delivery of tanshinone IIA and α-mangostin from gold/PEI/cyclodextrin nanoparticle platform designed for prostate cancer chemotherapy.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclodextrins; DNA Fragmentation; Drug Delivery Systems; Gold; Humans; Male; Microscopy, Electron, Transmission; Nanoparticles; Polyethyleneimine; Prostatic Neoplasms; Xanthones | 2016 |
New Insight of Tetraphenylethylene-based Raman Signatures for Targeted SERS Nanoprobe Construction Toward Prostate Cancer Cell Detection.
Topics: Cell Line, Tumor; Gold; Humans; Male; Nanostructures; Oligopeptides; Prostatic Neoplasms; Spectrum Analysis, Raman; Stilbenes | 2016 |
Polypeptide-Based Gold Nanoshells for Photothermal Therapy.
Topics: Cell Line, Tumor; Convection; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Low-Level Light Therapy; Male; Models, Biological; Models, Theoretical; Molecular Targeted Therapy; Nanoshells; Peptides; Phototherapy; Prostatic Neoplasms; Surface Plasmon Resonance | 2017 |
MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
Topics: Aged; Cluster Analysis; Feasibility Studies; Fiducial Markers; Gold; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pattern Recognition, Automated; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2016 |
Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Folic Acid; Gene Silencing; Gene Transfer Techniques; Genetic Therapy; Gold; Humans; Male; Metal Nanoparticles; Polyethylene Glycols; Prostate; Prostatic Neoplasms; RNA, Small Interfering | 2016 |
Label-free electrochemical aptasensing of the human prostate-specific antigen using gold nanospears.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Male; Nanostructures; Prostate-Specific Antigen; Prostatic Neoplasms | 2016 |
Amplification-Free Detection of Gene Fusions in Prostate Cancer Urinary Samples Using mRNA-Gold Affinity Interactions.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Electrochemical Techniques; Electrodes; Gold; Humans; Male; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Transcriptional Regulator ERG | 2016 |
Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy.
Topics: Animals; Cell Line, Tumor; Cone-Beam Computed Tomography; Gold; Humans; Male; Metal Nanoparticles; Mice, SCID; Pentetic Acid; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Theranostic Nanomedicine | 2016 |
Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications.
Topics: Fiducial Markers; Gold; Humans; Male; Pain, Postoperative; Perineum; Prostatic Neoplasms; Radiotherapy, Image-Guided | 2015 |
Non-invasive monitoring of branched Au nanoparticle-mediated photothermal ablation.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gold; Humans; Hyperthermia, Induced; Male; Metal Nanoparticles; Mice; Mice, SCID; Phototherapy; Positron-Emission Tomography; Prostatic Neoplasms | 2017 |
RETRACTED: Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; DNA Adducts; Doxorubicin; Drug Carriers; Gold; Humans; Hyperthermia, Induced; Male; Mice, Inbred BALB C; Mice, Nude; Nanotubes; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Receptors, LDL; Tumor Burden | 2016 |
Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)-Targeted Photothermal Therapy.
Topics: Antigens, Neoplasm; Cell Line, Tumor; Cell Survival; Convection; Gold; GPI-Linked Proteins; Humans; Hyperthermia, Induced; Immunoglobulins; Infrared Rays; Low-Level Light Therapy; Male; Models, Biological; Models, Theoretical; Molecular Targeted Therapy; Nanoshells; Neoplasm Proteins; Phototherapy; Prostatic Neoplasms; Surface Plasmon Resonance | 2017 |
Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing.
Topics: Cell Line, Tumor; Contrast Media; Cytoplasm; Gold; Humans; Magnetite Nanoparticles; Male; Nanoconjugates; Prostatic Neoplasms | 2016 |
Determining the Ratio of Two Types of Prostate Specific Antigens with Biochips and Gold Nanoparticles for Accurate Prostate Cancer Diagnosis.
Topics: alpha 1-Antichymotrypsin; Antibodies, Immobilized; Biomarkers; Biosensing Techniques; Calibration; Gold; Humans; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reference Values; Sensitivity and Specificity | 2016 |
Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies.
Topics: Colloids; Early Detection of Cancer; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Particle Size; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Spectrophotometry, Ultraviolet; Surface Plasmon Resonance | 2016 |
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor.
Topics: Cell Line, Tumor; Drug Design; Gold; Humans; Lasers; Male; Microscopy, Confocal; Microscopy, Electron, Transmission; Molecular Targeted Therapy; Nanoparticles; Peptides; Prostatic Neoplasms; Receptors, Neuropeptide Y; Theranostic Nanomedicine; Thermography | 2016 |
Transrectal implantation and stability of gold markers in prostate bed for salvage radiotherapy of macroscopic recurrences.
Topics: Fiducial Markers; Gold; Humans; Male; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Recurrence; Salvage Therapy; Tomography, X-Ray Computed | 2016 |
Local dose enhancement of proton therapy by ceramic oxide nanoparticles investigated with Geant4 simulations.
Topics: Cerium; Gold; Humans; Male; Metal Nanoparticles; Monte Carlo Method; Nanoparticles; Oxides; Prostatic Neoplasms; Proton Therapy; Radiation Dosage; Radiotherapy Dosage; Tantalum | 2016 |
Hybrid Synthetic Receptors on MOSFET Devices for Detection of Prostate Specific Antigen in Human Plasma.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Gold; Humans; Male; Oxides; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Artificial; Semiconductors; Transistors, Electronic | 2016 |
Beam distortion due to gold fiducial markers during salvage high-intensity focused ultrasound in the prostate.
Topics: Artifacts; Fiducial Markers; Gold; Humans; Male; Prostatic Neoplasms; Salvage Therapy; Ultrasound, High-Intensity Focused, Transrectal | 2017 |
Antitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Therapy; Gold; Heterografts; Hyperthermia, Induced; Male; Mice; Nanostructures; Neovascularization, Pathologic; Prostatic Neoplasms; RNA, Small Interfering; Treatment Outcome; Vascular Endothelial Growth Factor A | 2017 |
Development of a SERS Probe for Selective Detection of Healthy Prostate and Malignant Prostate Cancer Cells Using Zn
Topics: Biomarkers, Tumor; Gold; Humans; Male; Metal Nanoparticles; Molecular Probes; Molecular Structure; Particle Size; Prostate; Prostatic Neoplasms; Spectrum Analysis, Raman; Surface Properties; Zinc | 2017 |
Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Gold; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Palladium; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2017 |
An Enzyme-Free Signal Amplification Technique for Ultrasensitive Colorimetric Assay of Disease Biomarkers.
Topics: Biomarkers; Colorimetry; Enzyme-Linked Immunosorbent Assay; Gold; Humans; Iridium; Male; Metal Nanoparticles; Palladium; Particle Size; Prostate-Specific Antigen; Prostatic Neoplasms | 2017 |
A Monte Carlo study of I-125 prostate brachytherapy with gold nanoparticles: dose enhancement with simultaneous rectal dose sparing via radiation shielding.
Topics: Brachytherapy; Gold; Humans; Iodine Radioisotopes; Male; Metal Nanoparticles; Monte Carlo Method; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Urethra | 2017 |
Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.
Topics: Feasibility Studies; Fiducial Markers; Gold; Hematuria; Hemospermia; Humans; Image Interpretation, Computer-Assisted; Male; Pain Measurement; Perineum; Prospective Studies; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Surveys and Questionnaires; Tomography, X-Ray Computed | 2017 |
Interactions of Renal-Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity Effects.
Topics: Animals; Gold; Humans; Hydrogen-Ion Concentration; Kidney; Male; Metal Nanoparticles; Mice; Nanomedicine; Neoplasms, Experimental; Prostatic Neoplasms; Tissue Distribution; Tumor Microenvironment | 2017 |
Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles.
Topics: Cell Survival; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Radiation Tolerance | 2008 |
Fabrication of an electrically conductive mixed self-assembled monolayer and its application in an electrochemical immunosensor.
Topics: Electrochemistry; Gold; Humans; Male; Microscopy, Scanning Tunneling; Molecular Structure; Prostate-Specific Antigen; Prostatic Neoplasms; Sulfhydryl Compounds | 2008 |
The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI).
Topics: Body Weights and Measures; Gold; Humans; Imaging, Three-Dimensional; Male; Phantoms, Imaging; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy, Computer-Assisted; Reference Standards; Signal Processing, Computer-Assisted; Technology, Radiologic; Television; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2008 |
Off-line setup corrections only marginally reduce the number of on-line corrections for prostate radiotherapy using implanted gold markers.
Topics: Algorithms; Gold; Humans; Male; Online Systems; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Planning, Computer-Assisted | 2009 |
Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification.
Topics: Aged; Gold; Health Status; Humans; Male; Middle Aged; Prostatic Neoplasms; Prostheses and Implants; Quality of Life; Radiotherapy, Intensity-Modulated; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires | 2009 |
A semi-automated 2D/3D marker-based registration algorithm modelling prostate shrinkage during radiotherapy for prostate cancer.
Topics: Adenocarcinoma; Algorithms; Androgen Antagonists; Combined Modality Therapy; Gold; Humans; Imaging, Three-Dimensional; Male; Models, Theoretical; Prostate; Prostatic Neoplasms | 2009 |
Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Topics: Aged; Algorithms; Dose-Response Relationship, Radiation; Gold; Humans; Male; Models, Statistical; Prostatic Neoplasms; Prostheses and Implants; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Conformal; Rectum; Tumor Burden; Urinary Bladder | 2009 |
Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer.
Topics: Algorithms; Biomarkers; Gold; Humans; Male; Phantoms, Imaging; Prostatic Neoplasms; Protons; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2009 |
Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging.
Topics: Animals; Bombesin; Breast Neoplasms; Cattle; Cell Line, Tumor; Endocytosis; Female; Gold; Humans; Male; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Nanotubes; NIH 3T3 Cells; Prostatic Neoplasms; Receptors, Bombesin | 2009 |
Effectiveness of using fewer implanted fiducial markers for prostate target alignment.
Topics: Bone and Bones; Foreign-Body Migration; Gold; Humans; Imaging, Three-Dimensional; Male; Prostate; Prostatic Neoplasms; Prostheses and Implants; Proton Therapy; Reproducibility of Results; Software; Tomography, X-Ray Computed | 2009 |
Effect of translational and rotational errors on complex dose distributions with off-line and on-line position verification.
Topics: Gold; Humans; Magnetic Resonance Imaging; Male; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Seminal Vesicles; Tumor Burden; Urinary Bladder | 2009 |
Comparison of CT on rails with electronic portal imaging for positioning of prostate cancer patients with implanted fiducial markers.
Topics: Aged; Dose Fractionation, Radiation; Gold; Humans; Male; Movement; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity.
Topics: Aged; Aged, 80 and over; Biopsy; Gold; Humans; Male; Middle Aged; Pain; Pain Measurement; Prostatic Neoplasms; Prostheses and Implants; Surveys and Questionnaires; Ultrasonography, Interventional | 2009 |
Inferences about prostate intrafraction motion from pre- and posttreatment volumetric imaging.
Topics: Algorithms; Cone-Beam Computed Tomography; Dose Fractionation, Radiation; False Negative Reactions; False Positive Reactions; Fluoroscopy; Gases; Gold; Humans; Male; Movement; Organ Size; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Planning, Computer-Assisted; Rectum; ROC Curve; Sensitivity and Specificity; Supine Position; Urinary Bladder; Urine | 2009 |
Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer.
Topics: Artifacts; Feasibility Studies; Gold; Humans; Male; Particle Size; Phantoms, Imaging; Polymers; Prostatic Neoplasms; Prostheses and Implants; Proton Therapy; Radiotherapy Dosage; Scattering, Radiation; Tomography, X-Ray Computed | 2009 |
A prospective study of intrafraction prostate motion in the prone vs. supine position.
Topics: Brachytherapy; Gold; Humans; Male; Movement; Patient Positioning; Patient Satisfaction; Prone Position; Prospective Studies; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Seminal Vesicles; Supine Position; Tumor Burden | 2010 |
Contrast-enhanced radiotherapy: feasibility and characteristics of the physical absorbed dose distribution for deep-seated tumors.
Topics: Body Burden; Computer Simulation; Contrast Media; Feasibility Studies; Gold; Humans; Male; Models, Biological; Nanoparticles; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Relative Biological Effectiveness | 2009 |
Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle.
Topics: Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Flow Cytometry; Glucose; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2009 |
Enhanced surface plasmon resonance by Au nanoparticles immobilized on a dielectric SiO2 layer on a gold surface.
Topics: Gold; Humans; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Silicon Dioxide; Surface Plasmon Resonance | 2009 |
Image-guided radiotherapy in near real time with intensity-modulated radiotherapy megavoltage treatment beam imaging.
Topics: Algorithms; Gold; Humans; Male; Movement; Phantoms, Imaging; Point-of-Care Systems; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2009 |
Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Dose Fractionation, Radiation; Follow-Up Studies; Gold; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Prostheses and Implants; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Urogenital System | 2009 |
Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres.
Topics: Adsorption; Blood Proteins; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Drug Carriers; Endocytosis; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Osmolar Concentration; Particle Size; Polyethylene Glycols; Prostatic Neoplasms; Surface Properties | 2010 |
Rapid identification and quantification of tumor cells using an electrocatalytic method based on gold nanoparticles.
Topics: Antibodies, Monoclonal; Antigen-Antibody Reactions; B-Lymphocytes; Biosensing Techniques; Carbon; Catalysis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Electrochemistry; Electrodes; Gold; HLA-DR Antigens; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms | 2009 |
Nanomedicine: barcodes check out prostate cancer.
Topics: Antibodies; Biosensing Techniques; Gold; Humans; Male; Metal Nanoparticles; Nanomedicine; Prostate-Specific Antigen; Prostatic Neoplasms | 2010 |
Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Extracellular Space; Gold; Humans; Hyperthermia, Induced; Lasers; Male; Models, Biological; Nanotubes; Prostatic Neoplasms; Temperature; Time Factors | 2010 |
Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Antibodies; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Colonic Neoplasms; Diagnosis, Differential; Female; Gold; Humans; Immunoassay; Male; Membrane Proteins; Metal Nanoparticles; Middle Aged; Neoplasms; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Binding; Protein Conformation; Protein Tyrosine Phosphatases; Proteins; Sensitivity and Specificity | 2010 |
Optimized hybrid megavoltage-kilovoltage imaging protocol for volumetric prostate arc therapy.
Topics: Cineradiography; Dose Fractionation, Radiation; Gold; Humans; Image Interpretation, Computer-Assisted; Male; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2010 |
A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer.
Topics: Antigens, Surface; Aptamers, Nucleotide; Base Sequence; Cell Line, Tumor; Contrast Media; Doxorubicin; Glutamate Carboxypeptidase II; Gold; Humans; Male; Metal Nanoparticles; Nanoconjugates; Prostatic Neoplasms; Substrate Specificity; Tomography, X-Ray Computed | 2010 |
The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.
Topics: Animals; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Nanostructures; Nanotechnology; Prostatic Neoplasms; Xenograft Model Antitumor Assays; Zebrafish | 2010 |
Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.
Topics: Algorithms; Cone-Beam Computed Tomography; Dose Fractionation, Radiation; Fiducial Markers; Gold; Humans; Male; Movement; Patient Positioning; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tumor Burden | 2011 |
Position verification for the prostate: effect on rectal wall dose.
Topics: Anal Canal; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Movement; Patient Positioning; Prostate; Prostatic Neoplasms; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, X-Ray Computed; Tumor Burden; Urinary Bladder | 2011 |
Gold nanoparticle mediated detection of prostate cancer cells using photoacoustic flowmetry with optical reflectance.
Topics: Acoustics; Catechin; Flow Cytometry; Gold; Humans; Male; Metal Nanoparticles; Neoplastic Cells, Circulating; Prostatic Neoplasms; Signal Processing, Computer-Assisted | 2010 |
Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design.
Topics: Cone-Beam Computed Tomography; Fiducial Markers; Gold; Humans; Male; Movement; Patient Positioning; Prospective Studies; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Seminal Vesicles | 2011 |
Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies.
Topics: Antibiotics, Antineoplastic; Bleomycin; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; DNA, Neoplasm; Female; Gold; Humans; Lung; Lysosomes; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Organ Specificity; Prostatic Neoplasms; Radiation Dosage; Radiation Tolerance; Radiotherapy, High-Energy; Tumor Stem Cell Assay | 2011 |
Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy.
Topics: Cell Line, Tumor; Gold; Humans; Hyperthermia, Induced; Male; Metal Nanoparticles; Monitoring, Physiologic; Nanotechnology; Phototherapy; Prostatic Neoplasms; Spectrum Analysis, Raman | 2010 |
Microfluidic chip-based nanoelectrode array as miniaturized biochemical sensing platform for prostate-specific antigen detection.
Topics: Biosensing Techniques; Blood Chemical Analysis; Electrochemical Techniques; Equipment Design; Gold; Humans; Male; Metal Nanoparticles; Microelectrodes; Microfluidic Analytical Techniques; Microscopy, Electron, Scanning; Microtechnology; Nanostructures; Nanotechnology; Oxidation-Reduction; Prostate-Specific Antigen; Prostatic Neoplasms | 2011 |
Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
Topics: Animals; Gold; Male; Metal Nanoparticles; Mice; Mice, Nude; Microscopy, Electron, Transmission; Molecular Structure; Nanoconjugates; Organotechnetium Compounds; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Spectrophotometry, Infrared; Technetium | 2010 |
Multilayer coating of gold nanorods for combined stability and biocompatibility.
Topics: Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Drug Carriers; Gold; Humans; Male; Nanotubes; Phototherapy; Polymers; Prostatic Neoplasms; Silicon Dioxide; Surface-Active Agents | 2011 |
Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
Topics: Artifacts; Fiducial Markers; Gold; Humans; Magnetic Fields; Magnetic Resonance Imaging; Male; Movement; Patient Positioning; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2012 |
Positive potential operation of a cathodic electrogenerated chemiluminescence immunosensor based on luminol and graphene for cancer biomarker detection.
Topics: Biomarkers, Tumor; Biosensing Techniques; Electrodes; Glucose Oxidase; Gold; Graphite; Humans; Immunoassay; Luminescent Measurements; Luminol; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms | 2011 |
Synergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matrices.
Topics: Benzoquinones; Cell Line, Tumor; Cell Survival; Cysteine; Doxorubicin; Elastin; Gold; HSP90 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Lactams, Macrocyclic; Low-Level Light Therapy; Male; Nanoparticles; Nanotubes; Peptides; Prostatic Neoplasms | 2011 |
A facile nanoparticle immunoassay for cancer biomarker discovery.
Topics: Animals; Biomarkers, Tumor; Gold; Humans; Immunoassay; Male; Metal Nanoparticles; Mice; Prostatic Neoplasms; Vascular Endothelial Growth Factors | 2011 |
Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
Topics: Examination Tables; Fiducial Markers; Gold; Humans; Male; Movement; Patient Positioning; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy Setup Errors; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Time Factors; Tomography, X-Ray Computed | 2011 |
Long-range nanoparticle surface-energy-transfer ruler for monitoring photothermal therapy response.
Topics: Aptamers, Nucleotide; Cell Line; Cell Line, Tumor; Energy Transfer; Gold; Hot Temperature; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Monitoring, Physiologic; Nanomedicine; Optical Phenomena; Prostatic Neoplasms | 2011 |
Detection of localized inclusions of gold nanoparticles in Intralipid-1% by point-radiance spectroscopy.
Topics: Diagnostic Imaging; Emulsions; Gold; Humans; Male; Metal Nanoparticles; Optical Phenomena; Phantoms, Imaging; Phospholipids; Prostatic Neoplasms; Soybean Oil; Spectrum Analysis | 2011 |
Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement.
Topics: Fiducial Markers; Gold; Humans; Male; Patient Satisfaction; Prostatic Neoplasms; Ultrasonography, Interventional | 2011 |
Stability of serrated gold coil markers in prostate localization.
Topics: Aged; Computer Simulation; Gold; Hormones; Humans; Male; Prostatic Neoplasms; Prostheses and Implants; Radiographic Image Interpretation, Computer-Assisted; Radiotherapy Planning, Computer-Assisted; Time Factors | 2011 |
Reduction of treatment volume and radiation doses to surrounding tissues with intraprostatic gold markers in prostate cancer radiotherapy.
Topics: Gold; Humans; Male; Prostate; Prostatic Neoplasms; Radiation Oncology; Radiography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2011 |
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
Topics: Animals; Cell Line, Tumor; Female; Gold; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanotubes; Neovascularization, Pathologic; Peptides, Cyclic; Polyethylene Glycols; Prostatic Neoplasms; Spectrophotometry, Atomic; Sulfhydryl Compounds; Surface Plasmon Resonance; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |
MR temperature imaging of nanoshell mediated laser ablation.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Gold; Humans; Laser Therapy; Magnetic Resonance Imaging; Male; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoshells; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Heat shock protein expression and temperature distribution in prostate tumours treated with laser irradiation and nanoshells.
Topics: Animals; Cell Line, Tumor; Gold; Hot Temperature; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Laser Therapy; Magnetic Resonance Imaging; Male; Mice; Nanoshells; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
Topics: Aged; Disease-Free Survival; Fiducial Markers; Follow-Up Studies; Gastrointestinal Tract; Gold; Humans; Male; Neoplasm Grading; Organ Size; Organs at Risk; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies; Urogenital System | 2012 |
Fiducial markers in prostate for kV imaging: quantification of visibility and optimization of imaging conditions.
Topics: Carbon; Fiducial Markers; Gold; Humans; Male; Prostate; Prostatic Neoplasms; Proton Therapy; Radiation Dosage; Signal-To-Noise Ratio; Tomography, X-Ray Computed; Uncertainty | 2012 |
First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Topics: Dose Fractionation, Radiation; Fiducial Markers; Gold; Humans; Male; Movement; Prostate; Prostatic Neoplasms; Radiography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Rectum | 2012 |
Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate.
Topics: Biomarkers; Choline; Citrates; Creatine; Fiducial Markers; Gold; Humans; Magnetic Resonance Spectroscopy; Male; Phantoms, Imaging; Prostate; Prostatic Neoplasms | 2012 |
Daily prostate volume and position monitoring using implanted gold markers and on-board imaging during radiotherapy.
Topics: Fiducial Markers; Gold; Humans; Male; Organ Size; Patient Positioning; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
Rational aspect ratio and suitable antibody coverage of gold nanorod for ultra-sensitive detection of a cancer biomarker.
Topics: Antibodies, Immobilized; Gold; Humans; Limit of Detection; Male; Nanotubes; Prostate-Specific Antigen; Prostatic Neoplasms; Surface Plasmon Resonance | 2012 |
Immunogold labeling-induced synergy effect for amplified photoelectrochemical immunoassay of prostate-specific antigen.
Topics: Antibodies; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Quantum Dots | 2012 |
Image-based dynamic multileaf collimator tracking of moving targets during intensity-modulated arc therapy.
Topics: Algorithms; Equipment Design; Fiducial Markers; Gold; Humans; Lung Neoplasms; Male; Movement; Particle Accelerators; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy Setup Errors; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2012 |
Developing a nanoparticle test for prostate cancer scoring.
Topics: Adsorption; Gold; Humans; Immunoglobulin G; Male; Metal Nanoparticles; Models, Biological; Nanotechnology; Neoplasm Proteins; Prostatic Neoplasms; Serum; Solutions; Tissue Extracts | 2012 |
Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid-gold nanoparticle conjugates.
Topics: Equipment Design; Gene Expression Profiling; Gold; Humans; Male; MicroRNAs; Nanoparticles; Nucleic Acids; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Sensitivity and Specificity | 2012 |
Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Combined Modality Therapy; Fiducial Markers; Foreign-Body Migration; Gold; Humans; Male; Prostate; Prostatic Neoplasms; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2012 |
A gold nanocage-CNT hybrid for targeted imaging and photothermal destruction of cancer cells.
Topics: Cell Line, Tumor; Drug Delivery Systems; Fluoroimmunoassay; Gold; Humans; Hyperthermia, Induced; Male; Microscopy, Electron, Transmission; Nanostructures; Prostatic Neoplasms | 2012 |
MRI of prostate stem cell antigen expression in prostate tumors.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Immobilized; Antigens, Neoplasm; Gold; GPI-Linked Proteins; Humans; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Molecular Imaging; Molecular Targeted Therapy; Neoplasm Proteins; Neoplastic Stem Cells; Prostatic Neoplasms; Radiography | 2012 |
Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles.
Topics: Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endocytosis; Flow Cytometry; Gold; Humans; Lung; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Particle Size; Prostatic Neoplasms; Reactive Oxygen Species; Spectrophotometry, Atomic; Toxicity Tests | 2012 |
MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
Topics: Animals; Antibodies, Immobilized; Antibodies, Monoclonal; Antigens, Neoplasm; Biomarkers, Tumor; Cell Line, Tumor; Ferric Compounds; Gold; GPI-Linked Proteins; Humans; Immunotherapy; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Neoplasm Proteins; Prostatic Neoplasms; Tissue Distribution | 2012 |
Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells.
Topics: Androgen Antagonists; Cell Line, Tumor; Drug Resistance, Neoplasm; Gold; Hormones; Humans; Male; Metal Nanoparticles; Molecular Docking Simulation; Molecular Targeted Therapy; Particle Size; Prostatic Neoplasms; Receptors, Androgen | 2012 |
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Female; Gold; Gold Radioisotopes; Humans; Male; Metal Nanoparticles; Mice; Mice, SCID; Particle Size; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Topics: Amino Acid Sequence; Animals; Antigens, Tumor-Associated, Carbohydrate; Cancer Vaccines; Chemistry Techniques, Synthetic; Drug Design; Female; Glycopeptides; Gold; Humans; Immune Sera; Ligands; Male; Metal Nanoparticles; Mice; Molecular Sequence Data; Mucin-4; Prostatic Neoplasms | 2012 |
Plasmonic nanostructures for SERRS multiplexed identification of tumor-associated antigens.
Topics: Antigens, Neoplasm; Cell Line, Tumor; Gold; GPI-Linked Proteins; Humans; Kallikreins; Male; Metal Nanoparticles; Nanotechnology; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Spectrum Analysis, Raman; Surface Plasmon Resonance | 2012 |
Simultaneous electrochemical detection of multiple tumor markers based on dual catalysis amplification of multi-functionalized onion-like mesoporous graphene sheets.
Topics: Alkaline Phosphatase; Antibodies; Binding Sites; Biomarkers, Tumor; Biosensing Techniques; Catalysis; Electrochemical Techniques; Electrodes; Ferrocyanides; Gold; Graphite; Humans; Male; Metal Nanoparticles; Nickel; Prostate-Specific Antigen; Prostatic Neoplasms; Streptavidin | 2012 |
Influence of the number of elongated fiducial markers on the localization accuracy of the prostate.
Topics: Artifacts; Fiducial Markers; Gold; Humans; Male; Prostatic Neoplasms; Radiotherapy, Image-Guided; Rotation; Ultrasonography; Uncertainty | 2012 |
Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers.
Topics: Aged; Aged, 80 and over; Diagnostic Self Evaluation; Diarrhea; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organs at Risk; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Image-Guided; Rectum; Regression Analysis; Surveys and Questionnaires; Tumor Burden; Urinary Bladder; Urination Disorders | 2013 |
Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?
Topics: Gold; Humans; Male; Prostatic Neoplasms; Radiotherapy; Radiotherapy Dosage | 2012 |
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.
Topics: Antigens, Surface; Bacterial Proteins; Biotin; Cell Line, Tumor; Drug Delivery Systems; Glutamate Carboxypeptidase II; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Protein Binding | 2013 |
Highly sensitive immunosensing of prostate-specific antigen based on ionic liquid-carbon nanotubes modified electrode: application as cancer biomarker for prostate biopsies.
Topics: Biopsy; Biosensing Techniques; Cell Line, Tumor; Electrochemical Techniques; Gold; Humans; Immunoassay; Ionic Liquids; Male; Metal Nanoparticles; Nanotubes, Carbon; Prostate-Specific Antigen; Prostatic Neoplasms | 2013 |
Rapid and specific electrochemical detection of prostate cancer cells using an aperture sensor array.
Topics: Antibodies; Antigens, Neoplasm; Biosensing Techniques; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Electrochemical Techniques; Electrodes; Epithelial Cell Adhesion Molecule; Ferricyanides; Glass; Gold; Humans; Immunohistochemistry; Male; Neoplastic Cells, Circulating; Oxidation-Reduction; Prostatic Neoplasms | 2013 |
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy.
Topics: Adenocarcinoma; Computer Systems; Feasibility Studies; Fluoroscopy; Foreign-Body Migration; Gold; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Motion; Neurilemmoma; Particle Size; Prostatic Neoplasms; Prostheses and Implants; Radioisotope Teletherapy; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, High-Energy; Reproducibility of Results; Spinal Neoplasms; Tomography, X-Ray Computed | 2003 |
(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device.
Topics: Gold; Humans; Male; Movement; Prostate; Prostatic Neoplasms; Time Factors; Tomography, X-Ray Computed | 2003 |
Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials.
Topics: Cluster Analysis; Gold; Humans; Male; Movement; Patient Care Planning; Pelvic Bones; Posture; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Tomography, X-Ray Computed | 2003 |
Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device.
Topics: Calibration; Feasibility Studies; Gold; Humans; Male; Movement; Prospective Studies; Prostate; Prostatic Neoplasms; Radiography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2003 |
Treatment of carcinoma of the prostate by interstitial radiation with radio-active gold (Au 198): a preliminary report.
Topics: Brachytherapy; Carcinoma; Gold; Gold Radioisotopes; Humans; Male; Prostatic Neoplasms | 1952 |
Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer.
Topics: Gold; Humans; Male; Movement; Obesity, Morbid; Prostatic Neoplasms; Radiography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2004 |
[Three dimensional conformal radiotherapy (3D-CRT) for localized prostate cancer under field adjustment with implanted gold markers: early clinical outcome].
Topics: Aged; Androgen Antagonists; Combined Modality Therapy; Drug Implants; Gold; Humans; Laparoscopy; Lymph Node Excision; Male; Middle Aged; Prostatic Neoplasms; Radiotherapy, Conformal; Treatment Outcome | 2004 |
Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Prospective Studies; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Statistics, Nonparametric; Tomography, X-Ray Computed | 2005 |
Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols.
Topics: Gold; Humans; Male; Movement; Normal Distribution; Prone Position; Prostatic Neoplasms; Prostheses and Implants; Radiography; Retrospective Studies; Supine Position | 2005 |
Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging.
Topics: Gold; Humans; Male; Movement; Pelvic Bones; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiographic Image Enhancement | 2005 |
Influence of intrafraction motion on margins for prostate radiotherapy.
Topics: Algorithms; Dose Fractionation, Radiation; Electromagnetic Phenomena; Gold; Humans; Male; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy, Conformal; Retrospective Studies; Supine Position; Time Factors | 2006 |
In regard to Litzenberg et al.: Retrospective analysis of prostate patients with implanted gold markers using off-line and adaptive therapy protocols (Int J Radiat Oncol Biol Phys 2005;63:123-133).
Topics: Gold; Humans; Male; Movement; Prone Position; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy, Computer-Assisted; Retrospective Studies; Supine Position | 2006 |
Clinical application of a repositioning scheme, using gold markers and electronic portal imaging.
Topics: Algorithms; Carcinoma; Gold; Humans; Male; Movement; Pelvic Bones; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rotation | 2006 |
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
Topics: Contrast Media; Feasibility Studies; Gold; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pilot Projects; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, X-Ray Computed | 2006 |
Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode.
Topics: Electronics, Medical; Gold; Humans; Male; Prostate; Prostatic Neoplasms; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Treatment Outcome | 2006 |
A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapy.
Topics: Gold; Humans; Male; Observer Variation; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Prostheses and Implants; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer.
Topics: Gold; Humans; Immobilization; Infrared Rays; Lasers; Male; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy, Intensity-Modulated; Skin; Ultrasonography | 2006 |
A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers.
Topics: Aged; Finite Element Analysis; Gold; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Reproducibility of Results; Transurethral Resection of Prostate | 2007 |
Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer.
Topics: Clinical Protocols; Gold; Humans; Linear Models; Male; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Rotation | 2007 |
Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy.
Topics: Calibration; Gold; Humans; Male; Movement; Prostate; Prostatectomy; Prostatic Neoplasms; Prostheses and Implants; Radiography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Salvage Therapy | 2007 |
Monte Carlo simulations of dose near a nonradioactive gold seed.
Topics: Computer Simulation; Gold; Humans; Male; Models, Theoretical; Monte Carlo Method; Particle Accelerators; Phantoms, Imaging; Photons; Prostatic Neoplasms; Radiation Dosage; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2006 |
Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.
Topics: Artifacts; Feasibility Studies; Gold; Humans; Male; Observer Variation; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy, Computer-Assisted; Tomography, X-Ray Computed | 2007 |
Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Gastrointestinal Hemorrhage; Gold; Hematuria; Hemospermia; Humans; Male; Middle Aged; Pain; Prostate; Prostatic Neoplasms; Prostheses and Implants; Rectal Diseases; Risk Factors; Surveys and Questionnaires; Ultrasonography, Interventional | 2007 |
Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.
Topics: Gold; Humans; Male; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy, Intensity-Modulated | 2007 |
Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning.
Topics: Finite Element Analysis; Gold; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, X-Ray Computed; Urinary Bladder | 2007 |
Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro.
Topics: Catheter Ablation; Cell Death; Cell Line, Tumor; Cell Survival; Gold; Humans; In Vitro Techniques; Lasers; Male; Minimally Invasive Surgical Procedures; Nanospheres; Prostatic Neoplasms | 2007 |
Prostate planning treatment volume margin calculation based on the ExacTrac X-Ray 6D image-guided system: margins for various clinical implementations.
Topics: Gold; Humans; Male; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2007 |
Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods.
Topics: Dose Fractionation, Radiation; Gold; Humans; Male; Movement; Pelvic Bones; Prostate; Prostatic Neoplasms; Prostheses and Implants | 2008 |
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
Topics: Animals; Cell Line, Tumor; Gold; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Organ Specificity; Particle Size; Prostatic Neoplasms; Tissue Distribution | 2007 |
Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK department.
Topics: Aged; Brachytherapy; Gold; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Prostatic Neoplasms; Radiotherapy, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2008 |
A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.
Topics: Aged; Bone and Bones; Clinical Protocols; Feasibility Studies; Foreign-Body Migration; Gold; Humans; Male; Middle Aged; Movement; Prostate; Prostatic Neoplasms; Prostheses and Implants; Radiography; Retrospective Studies | 2008 |
Selective prostate cancer thermal ablation with laser activated gold nanoshells.
Topics: Animals; Disease Models, Animal; Electrocoagulation; Gold; Laser Therapy; Male; Metal Nanoparticles; Mice; Mice, Nude; Prostatic Neoplasms | 2008 |
Detection of free prostate specific antigen (fPSA) on a nanoporous gold platform.
Topics: Alkaline Phosphatase; Biomarkers, Tumor; Electrochemistry; Gold; Humans; Immunoassay; Male; Nanotechnology; Prostate-Specific Antigen; Prostatic Neoplasms; Spectrophotometry | 2008 |
Technique for implantation of fiducial markers in the prostate.
Topics: Biopsy, Needle; Electromagnetic Phenomena; Equipment Design; Gold; Humans; Male; Prostate; Prostatic Neoplasms; Prostheses and Implants; Prosthesis Implantation; Radiotherapy; Ultrasonography | 2008 |
Variability and accuracy of measurements of prostate brachytherapy seed position in vitro using three-dimensional ultrasound: an intra- and inter-observer study.
Topics: Agar; Analysis of Variance; Brachytherapy; Gold; Humans; Image Processing, Computer-Assisted; Male; Models, Statistical; Observer Variation; Phantoms, Imaging; Prostatic Neoplasms; Radiometry; Rectum; Reproducibility of Results; Tomography, X-Ray Computed; Ultrasonics | 2000 |
Feasibility of automatic marker detection with an a-Si flat-panel imager.
Topics: Algorithms; Gold; Humans; Implants, Experimental; Male; Prostate; Prostatic Neoplasms; Radiography; Radiotherapy, Conformal; Silicon | 2001 |
Immunogold probes for electron microscopy: evaluation of staining by fluorescence microscopy.
Topics: Adenocarcinoma; Animals; Cell Line; Cytoskeleton; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Gold; Immunologic Techniques; Keratins; Male; Microscopy, Electron; Prostatic Neoplasms; Rats; Staining and Labeling; Thiocyanates | 1985 |
Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex.
Topics: Adenocarcinoma; Antigens; Antigens, Neoplasm; Gold; Humans; Male; Microscopy, Electron; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Staphylococcal Protein A | 1987 |
Prostate localization for the treatment planning of prostate cancer: a comparison of two techniques.
Topics: Gold; Humans; Male; Prostate; Prostatic Neoplasms; Radiotherapy; Tomography, X-Ray Computed; Urography | 1988 |